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RÉSUMÉ 
Les blessures médullaires et les lésions étendues des nerfs handicapent des milliers de nouvelles 
personnes chaque année aux États-Unis seulement. Il n’y a actuellement aucun traitement 
permettant la guérison de ces blessures. Une approche envisagée est la greffe de structures 
chargées de cellules souches pour rétablir les fonctions originelles du tissu. Ce travail vise donc à 
développer une méthode de fabrication d’une structure qui puisse offrir un support mécanique 
aux cellules, tout en délivrant sur place le cocktail de biomolécules adéquat pour diriger la 
différenciation des cellules vers le phénotype de neurone moteur. Afin de préparer cette 
structure, de la gélatine et de l’acide polylactique-L ont été co-électrofilés. L’électrofilage permet 
la fabrication de fibres de diamètre dépendant de la concentration des solutions en polymère. Les 
fibres ainsi fabriquées ont été réticulées afin de ralentir et contrôler leur dégradation. Les 
biomolécules permettant de promouvoir la différenciation des cellules en neurones moteurs, 
l’acide rétinoïque et la purmorphamine, ont été incluses dans la partie extérieure des fibres, en 
gélatine. Ces molécules ont diffusé de manière continue à partir des fibres, dans le milieu 
liquide. Les cellules implantées sur cette structure ont proliféré et se sont différenciées en 
neurones moteurs. Leur phénotype a été caractérisé par immunofluorescence.  
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ABSTRACT 
Spinal cord injury and extended nerve injury currently have no cure. These pathologies are 
responsible for the decrease in quality of life of thousands of new people every year in the US 
only, and are draining huge costs to the healthcare system. Current research in the area focuses 
on the grafting of an artificial structure loaded with stem cells to restore tissue functions. The 
objective of this work is to propose a structure that can offer mechanical support to the cells, 
favor their proliferation, and promote their differentiation into motor neuron, by delivering in 
situ the appropriate cocktail of growth factors. Such structure was prepared by co-
electrospinning of poly L-lactic acid and gelatin. Fiber diameter can be adjusted by controlling 
the polymer concentration. These fibers were crosslinked to slow their degradation. Retinoic acid 
and purmorphamine were included in the outer layer of gelatin. These two growth factors are 
known to direct cell differentiation towards a motor neurons phenotype and were continuously 
released from the fibers in the medium. Cells proliferated on the structure and differentiated into 
motor neurons. Their phenotype was characterized by immunostaining using sample images. 
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INTRODUCTION 
Une multitude d’accidents peuvent occasionner des lésions des nerfs, voire de la moelle 
épinière, entrainant une baisse notable de la qualité de vie des patients. 
En effet, bien que des nerfs périphériques blessés sur de courtes distances puissent se 
régénérer, si la blessure est trop importante ou touche la moelle épinière, la régénération du tissu 
nerveux se fait difficilement. [1] Cette mauvaise régénération du tissu est due à la fois à une 
activité réduite des cellules souches neuronales, ce qui diminue la plasticité du tissu nerveux, et à 
la présence de tissu cicatriciel gênant la régénération du tissu originel. [2] Ces raisons font que la 
thérapie par cellules souches est toute indiquée pour pallier à ce genre de pathologie. En effet, ces 
thérapies impliquent l’injection de cellules souches pour pallier au manque du patient et restaurer 
la capacité du tissu à se régénérer. 
Les cellules souches ont la capacité de se multiplier et de se différencier, théoriquement, 
selon les stimuli environnementaux, en n’importe quel type cellulaire. Par conséquent, il est 
nécessaire de pouvoir contrôler leur différenciation. Les principaux facteurs qui influencent le 
phénotype vers lequel une cellule souche évoluera sont les propriétés mécaniques de son 
environnement, la topologie de son support qui doit copier la matrice extracellulaire et les 
facteurs de croissance qu’elle reçoit. Il est désormais connu que des cellules souches neuronales 
se différencieront en neurones moteur si elles reçoivent les concentrations adéquates d’acide 
rétinoïque et de sonic hedgehog. [3] D’autre part, il a été récemment découvert que la 
purmorphamine a les mêmes effets sur les cellules que sonic hedgehog. [3] 
L’utilisation de cellules souches pour de telles thérapies requiert la fabrication d’une 
structure support qui d’une part offre un milieu aux propriétés mécaniques satisfaisantes guidant 
l’étalement des cellules et d’autre part évite la migration anarchique des cellules souches 
injectées. Différentes techniques ont donc été développées pour permettre l’implantation d’une 
structure chargée de cellules souches dans la zone blessée. Un problème majeur des méthodes 
proposées jusqu’alors est que la différenciation des cellules souches implantées nécessite la 
présence de facteurs de croissance qui ne sont pas produits par le patient dans la zone blessée et 
dont la concentration doit être très finement contrôlée. La majorité des techniques mises au point 
à l’heure actuelle offrent bien un support mécanique aux cellules injectées, mais ne permettent 
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pas le contrôle de leur différenciation. Elles requièrent donc en général une injection externe de 
ces facteurs. [4] La mise en place de telles techniques sur l’homme n’est pas envisageable car 
elles demandent des opérations chirurgicales répétées beaucoup trop lourdes,  et une 
administration très régulière de ces molécules signal, afin d’obtenir un stimulus contrôlé de leur 
concentration dans l’environnement entourant les cellules.  
Dans ce contexte, les travaux les plus récents réalisés dans le domaine ont comme objectif 
la fabrication de structures qui puissent à la fois offrir un support mécanique aux cellules afin de 
permettre leur adhésion, d’organiser spatialement leur croissance, et, le cas échéant, de 
promouvoir leur multiplication avant implantation, mais qui puissent aussi diffuser directement in 
situ et à la bonne concentration les facteurs de croissance requis pour contrôler la différenciation 
desdites cellules. [5] 
L’objectif de ce travail est d’utiliser l’électrofilage pour fabriquer une telle structure. 
Cette technique permet l’obtention de fibres de diamètre variable à partir de différents polymères. 
Nous proposons d’utiliser l’électrofilage concentrique de deux polymères, la gélatine (couche 
externe) et l’acide poly-lactique (cœur interne) afin de bénéficier à la fois des propriétés 
mécaniques des fibres en acide poly-lactique et des bonnes propriétés de contact et de 
biocompatibilité de la gélatine. En plus d’offrir un bon support mécanique, la structure 
développée doit pouvoir délivrer des facteurs de croissance. 
La première partie de ce mémoire présente une revue de la littérature sur les techniques 
actuellement étudiées dans le but d’obtenir la régénération de tissus nerveux.  
La seconde partie, reprenant les concepts les plus intéressants exposés dans notre revue de 
littérature, propose, à notre avis, la technologie la plus prometteuse pour fabriquer une structure 
permettant de promouvoir la prolifération et la différenciation des cellules souches en neurones 
moteurs. Dans cette partie, les propriétés mécaniques et la dégradation du matériel sont étudiées. 
Ensuite la vitesse d’élution des biomolécules est évaluée et, finalement, la capacité de ce nouveau 
matériel à promouvoir la différenciation des cellules souches neuronales en neurones moteurs est 
validée par l’analyse d’images obtenues par immunofluorescence. 
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CHAPITRE 1 DÉMARCHE GÉNÉRALE 
Ce mémoire présente deux articles. Le premier, intitulé « Approaches for neural tissue 
regeneration » a été soumis dans Stem cells reviews and reports le 17 juillet 2013. Cet article 
permet d’exposer l’ensemble des techniques étudiées actuellement dans le but d’obtenir la 
génération de nouveaux tissus à partir de cellules souches. Les connaissances développées dans 
cette revue permettent de juger des avantages de chacune des techniques connues, et de faire un 
choix éclairé parmi celles-ci pour répondre à nos objectifs. Le second, intitulé “Differentiation of 
neuronal stem cells into motor neurons using co-axial electrospun Poly-L-Lacctic Acid/gelatin 
fibers as an instructive cue-delivering scaffold”, a été soumis dans Biomaterials le 20 Août 2013. 
Ces journaux scientifiques ont été sélectionnés pour leur niveau d’impact dans le domaine 
étudié ; Biomaterials étant le journal de référence pour la fabrication de structures en génie 
tissulaire alors que Stem cells reviews and reports publie des protocoles et revues de littératures 
sur les techniques émergentes dans le domaine.  
J’ai réalisé moi-même l’essentiel des travaux expérimentaux, une partie de la 
caractérisation de la dégradation des fibres a été réalisé sous ma supervision par Charlène Tendey 
au cours de son stage de fin d’étude. J’ai aussi bénéficié de l’expérience de mes directeur et co-
directeurs au cours de ces travaux et de la rédaction des articles. 
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CHAPITRE 2 REVUE DE LITTÉRATURE 
Il existe différentes approches étudiées dans le cadre du génie tissulaire appliqué aux tissus 
nerveux. Toutes ces approches ont un objectif similaire qui est de promouvoir la différenciation 
de cellules souches neuronales en un des types de neurones ou en cellules de Schwann. Elles 
visent généralement des applications soit dans le système nerveux périphérique ou la moelle 
épinière, afin le plus souvent de réparer des nerfs endommagés, soit dans le système nerveux 
central avec des applications plus tournées vers les maladies neuro-dégénératives. Bien que les 
champs d’application varient légèrement, les méthodes envisagées sont très similaires 
technologiquement, et une revue de l’ensemble de ces approches est proposée ici dans un 
manuscrit récemment soumis au journal Stem cells reviews and reports. 
 
 
Article 1 – Approaches for neural tissue regeneration 
 
 
 
 
Loïc BINAN, Abdellah AJJI, Gregory DE CRESCENZO, Mario JOLICOEUR 
“Approaches for neural tissue regeneration” 
Soumis dans «Stem cell reviews and reports » le17 juillet 2013. 
Manuscript ID. STCR-883 
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 Abstract 
There is currently no treatment for neurodegenerative diseases such as Parkinson’s or 
Alzheimer's diseases. While spinal cord injury has no treatment either, nerve injuries are 
being treated with autologous grafts, a procedure that in turn translates into a loss of 
function in the donor area. The development of therapies for these pathologies has become 
urgent as population keeps on ageing. A promising direction of investigation is the use of 
regenerative techniques to re-grow healthy and functional tissue in the injured area. In this 
review article, various approaches currently investigated to promote neural regeneration 
are covered. Those include approaches based on (and many times combining) stem cell 
therapy, scaffolds made of hydrogel, electrospun fibers and conductive materials as well as 
the use of soluble or non-diffusible growth factors. 
 
Keywords 
Nerve, spinal cord; stem cell, regeneration, biomaterial, scaffold, hydrogel, electrospinning, 
growth factor. 
 
2.1 Introduction 
16 million first-ever strokes occur every year, which makes it the second cause of death 
worldwide after heart diseases, with associated costs over 65 billion dollars in the United States 
only. [6] Also, 12,000 new cases of spinal cord injury (SCI) occur every year, with 270,000 
people seeing their life quality highly affected. [7] Moreover, every year, 60,000 new cases of 
Parkinson’s disease are diagnosed, for a total of 7 to 10 million people worldwide. [8] However, 
there is currently no appropriate cure for all these affections and the research in this field is still 
in its infancy. Pathologies affecting neural tissues can be divided into two classes: those that 
come from an injury, where the neuronal tissue is physically damaged; and neurodegenerative 
diseases, where the tissue loses its functions with time, and ultimately dies. For the first class, the 
use of autologous grafts to repair damaged nerves is now possible in many cases. [9] This 
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surgical solution consists in taking a nerve, usually with a sensory function from a healthy area, 
and grafting it in the injured area to serve as a guide for the regrowth of the motoneurons. [9] 
However, this approach leads to a loss of function in the donor area, and, in most cases, function 
recovery at the site of implantation does not reach expected levels. [11] For the second class of 
diseases, there is no actual treatment targeting the cause of the symptoms. Current medical 
treatments are aimed at slowing down the disease progression and/or minimizing its impacts on 
patients’ quality of life. For instance, dopamine and dopamine agonists are administered to 
patients suffering from Parkinson’s disease in order to compensate for the lack of dopamine 
inside the brain and thus attenuate symptoms. [12] The difficulties faced when trying to provide 
an appropriate and complete treatment to those pathologies lie in the fact that it would require the 
restoration of tissue function, and re-growth of tissue replacing the dead one. By itself, current 
medication does not appear to be a solution for those two issues since, once those diseases are 
developed, the site of the pathology becomes hostile to tissue re-growth, which impedes the body 
regenerating healthy tissue. [13] 
 
It has long been considered that once damaged, a neuronal tissue does not regenerate. Indeed, it 
was thought that, contrary to other tissues, neuronal tissue did not contain any stem cells, and 
therefore would not regenerate. Nevertheless, the recent discovery that nervous tissue is actually 
more dynamic than expected and that it contains stem cells has opened new therapeutic avenues 
based on a regenerative medicine approach. [14] This opportunity resides on the hypothesis that 
stem cells may have the same regenerative abilities in neural tissue as in other cases and are able 
to promote tissue regeneration. A remaining issue that may mitigate the use of stem cell-based 
therapies for neural tissues is that the number of active neural stem cells is thought to be very 
low. It is indeed admitted that stem cells do not divide continuously but that they specifically 
enter cycles of divisions, which prevents cell depletion in the tissue. It is thought that stem cells 
from the subventricular zone (SVZ) have a longer quiescence sequence between their cycles of 
proliferation than other stem cells. In fact, it has been suggested by Hwang and colleagues that 
glial cells might actually be the very stem cells of the nervous system. [15] Future stem cell-
based regenerative strategies thus require either the use of stimuli in vivo or the addition of an in 
vitro step aiming at amplifying the patient's active neuronal stem cells prior to their re-
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implantation as cells or tissue. Injuries that could be potentially treated with such a tissue 
regeneration or replacement technique are those related to nerve or spinal cord damages, or loss 
of function such as in Parkinson's, Huntington's or Alzheimer's diseases. For neurodegenerative 
diseases, the strategy may be directed toward the synthesis of a tissue presenting normal activity 
and thus re-establishing endogenous tissue function. For instance, in Parkinson’s disease, the new 
tissue would be expected to synthesize dopamine up to normal levels in the substancia nigra and 
improve the patient’s quality of life. [16] These approaches are particularly promising since 
damaged areas become hostile to the growth of new tissue, and would not allow for the re-growth 
of healthy tissue without any intervention except in highly rare cases. [13] 
Although the discovery of neural stem cells has paved the way for innovative and efficient 
regenerative therapies, there are still several issues that remain to be solved before routinely 
applying such techniques. First, cell implantation and connection with host tissue need to be 
improved and cell growth and differentiation into desired phenotype(s) must be controlled, more 
likely through the use of growth factor(s) or related stimuli. Furthermore, structures supporting 
cell growth, possibly combined to growth factors delivery ability, still need to be developed. This 
review aims at presenting the various emerging techniques that are proposed for neural tissue 
regeneration. 
 
2.2 Injection of free cells for in situ tissue regeneration 
In 2006, experimental observations reported that stem cells are produced in specific regions of 
the brain and then migrate to their final destination, allowing for brain plasticity even at the adult 
stage. [14] This observation led to the conclusion that neuronal tissue is more likely to be able to 
regenerate, thus opening promising opportunities to cure neuronal diseases. The presence of 
endogenous stem cells in neural tissue indeed suggests that it should be possible to obtain the 
same kind of tissue production in other parts of the brain or nerves by providing those progenitors 
cells. [14] Indeed, the injection of additional stem cells at the site of injury has first been 
proposed to enhance the regenerative effect of endogenous cells. In that endeavor, mesenchymal 
stem cells (MSCs) were selected since they are easy to amplify, protect themselves from the 
immune system, and can differentiate into neural lineage in vitro and in vivo. [17] MSC-derived 
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neural progenitors were injected directly in the diseased area of the brain in mice that had chronic 
experimental autoimmune encephalomyelitis. Those injections contributed to maintain normal 
phenotype of the tissue. [18] The beneficial effect of MSC upon new tissue formation was partly 
attributed to the extracellular matrix (ECM) produced by the MSCs, which created a reservoir of 
bioactive substances being responsible for this neuro-supportive environment at the injury site. 
[17, 19] 
Of salient interest, the benefits of stem cell therapy may also be extended to spinal cord injuries 
as demonstrated by Cummings and coworkers: human neuronal stem cells (hNSCs) cultured as 
neurospheres were directly injected in spinal cord-injured mice. [20] After 17 weeks, locomotor 
recovery and remyelination were observed even in myelin-deficient mice. More interestingly, 
SEM microscopy showed evidence of synapse formation between injected and endogenous cells, 
and cells migrated in the gray and white matters without participating to the formation of scar 
tissue in the injured area. 
Human embryonal carcinoma-derived cells have also been identified as a potential source of stem 
cells. Their transplantation has been shown to promote the recovery of normal motor capacity in 
a rat animal model. [21] More specifically, transplantation was performed in rats that 
demonstrated a deficiency in the passive avoidance test one month after the surgical injury of 
their neural tissue. Following cell transplantation, a partial recovery of the learning capacity was 
observed one month after treatment and lasted over 6 months. Heine and colleagues also 
promoted nerve regeneration in chronically denervated mice. [22] The team used an immortalized 
neural progenitor mouse cell line (C17.2 cells), to be transplanted into mice having a deficiency 
in the regeneration of their tibial nerve. Those mice were observed for four months and 
demonstrated improved physiological recovery when compared to control population. Their 
nerves presented increased amount of axons and reinervation of the muscular tissue of the foot. 
The team also reported that the transplanted cells were still present in the nerve region, but they 
were not presenting neuron phenotype. The latter observation strongly suggested that stem cells 
participated in the regeneration by providing growth factors to endogenous cells, and that those 
endogenous cells were the essential component of the newly generated nerve. 
Munoz et al. injected human MSCs into the dentate gyrus of the hippocampus of mice and 
obtained a colonization of the whole dorsal area of the hippocampus. [23] Implanted cells were 
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shown to promote endogenous cell proliferation. New cells were also observed to migrate 
through the brain for 30 days. After this period, those migrated cells presented markers of 
oligodendrocytes and mature neurons. In addition, human MSCs were shown to stimulate the 
production of neuronal survival factors such as nerve growth factor (NGF), vascular endothelial 
growth factor (VEGF), basic fibroblast growth factor-2 (FGF-2) and ciliary neurotrophic factor 
(CNTF), as well as to promote the proliferation of endogenous cells. Altogether, these studies 
suggested that the benefic effect of stem cell injections might be attributed to their ability to 
produce the adequate growth factors on site, these instructive cues leading to the remodeling of 
surrounding endogenous tissues, rather than to the creation of de novo tissue from differentiating 
stem cells. These conclusions in turn suggest that the injection of the adequate set of instructive 
cues may be sufficient to obtain similar spectacular effects without stem cell injection.  
 
2.3 Use of growth factors to promote healthy tissue re-growth 
2.3.1 In situ growth factor injection 
As illustrated in the previous section, stem cell injection has already given very positive results in 
terms of function recovery. These promising results may however be mitigated as cell injection 
may result in tumor formation. [24] In addition, most of the effects obtained with free stem cell 
injection have been attributed so far to the growth factors these cells produced rather than from 
their ability to differentiate and form new tissue. These conclusions have led to the hypothesis 
that the delivery of specific growth factors, rather than stem cells, may be favorable for 
regeneration. In support to this hypothesis is the fact that, in contrast to central nervous system 
(CNS) neurons, injured peripheral motoneurons are able to regenerate their axons thanks to 
neurotrophic factors provided by Schwann cells. Their ability to regenerate is however transient, 
probably because levels of neutrophic factors rapidly decline after injury. Schwann cell capacity 
to support axonal regeneration was also shown to be enhanced strongly when Schwann cells 
extracted from six-month chronically denervated sciatic nerve were cultured in vitro in the 
presence of transforming growth factor β (TGF-β) and forskolin prior to re-implantation. [25] 
Injection of growth factors and cytokines directly at the injury site has also been tested to 
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promote tissue regeneration. In that line of thinking, Kobayashi and colleagues demonstrated that 
specific neurotrophins, when continuously delivered to the damaged area by cannula, prevented 
the atrophy of axotomized neurons. [26] Growth factor infusion was correlated to the persistence 
of high mRNA levels for GAP-43, Tα1-tubulin and TrkB (the BDNF receptor). The effect of the 
treatment was still observed 14 days after the last injection, more likely due to the long-term 
stimulation of these regeneration-associated genes that acted in synergy with the delivered 
growth factors. Other synergistic effects mediated by the co-injection of growth factors have also 
been documented after sciatic nerve axotomy: Boyd and Gordon demonstrated that long-term co-
administration of glial cell line-derived neurotrophic factor (GDNF) combined with BDNF 
efficiently promoted axonal regeneration of motoneurons. [27] When used in combination with 
BDNF, GDNF was found to increase the number of axons per Schwann cell in vivo. Growth 
factor effects were however only observable after seven days of continuous injection. 
 
Strategies based on growth factors (Table 1) may thus be viable, although the need of continuous 
delivery by infusion, as originally tested in rat models, may represent a serious impediment for its 
translation to human. Therefore it appears necessary to develop novel experimental approaches 
that would allow for the growth factors to be delivered in situ in a spatio-temporally controlled 
fashion with minimal surgical intervention. 
 
2.3.2 Use of encapsulated growth factors to promote axonal regeneration 
and replace injured tissue 
Classical engineered growth factors delivery systems are based on their diffusion from hydrogel 
or porous polymeric material, or on the degradation of a polymeric scaffold in which they are 
freely entrapped or, alternatively, at the surface of which they are grafted. Depending on the 
design of the system, growth factor delivery can be controlled via pure diffusion through porous 
polymeric material or through polymer degradation. [28-30] When designing such scaffolds, 
important characteristics to be taken into account and evaluated are the drug loading capacity of 
the polymer construct and its degradation time, if needed. Also, the biocompatibility and 
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biosafety of degradation products are strictly required. Among biodegradable polymers envisaged 
for brain-specific applications and currently used as delivery systems in vitro or in in vivo animal 
models, poly lactic co-glycolic acid (PLGA) has been widely studied. [31-33] This Food and 
Drug Administration (FDA)-approved biodegradable synthetic polymer is mainly used to mimic 
the extracellular matrix mechanical properties and shape, as well as to strengthen scaffolds 
originally engineered from natural materials such as gelatin or elastin. [34] VEGF and BDNF 
encapsulation in PLGA microspheres has been reported by Wang and colleagues using the water-
in-oil-in-water encapsulation method. [35] The microspheres were then embedded within a 
crosslinked hyaluronic acid (HA) hydrogel to serve as scaffold for the culture of neural stem 
cells. The group demonstrated that such a design allowed for a slow and linear delivery of both 
growth factors for 6 days, with both encapsulated BDNF and VEGF maintaining their 
respectively known protective and pro-proliferative properties. The same strategy has been used 
to deliver CNTF from photopolymerizable nanoarray hydrogels. [36] However, a major issue 
related to the encapsulation of growth factors resides in the difficulty to obtain long-term delivery 
within a defined concentration range. Hydrogels indeed rapidly release most of the growth factors 
they contain in an initial burst that is higher than physiological levels, a phenomenon that reduces 
the duration of the delivery. [37] [38] 
 
The most-often encountered problem is that a longer delivery time requires sufficient loading of 
the structure, which in turn usually results in unwanted burst of delivered growth factor just after 
hydrogel injection. In an attempt to address this shortcoming, Betram et al. obtained their best 
results for NGF delivery with microspheres of PLGA-PLLA-PEG. [37] This combination 
suppresses the burst in secretion observed with PLGA-only hydrogels by controlling growth 
factor delivery through continuous degradation rather than desorption process. With that 
enhanced system, NGF was delivered up to 65 days without any observable burst.  
An alternative to growth factor encapsulation resides in growth factor direct blending with the 
polymer that constitutes the scaffold, during its fabrication. The scaffold will then release the 
included growth factors when degrading in the implantation area. In order to control cell 
differentiation, retinoic acid (RA)-containing poly(lactic-co-glycolic) acid electrospun fibers have 
been prepared by its incorporation with the polymer before electrospinning. RA was uniformly 
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present inside the construct and 80% of the loaded RA was released in 105 days at a constant 
rate. [39] Johnson et al. demonstrated the ability of scaffolds made of fibrin to deliver 
neurotrophin-3 (NT3) and platelet-derived growth factor (PDGF) in vivo. These scaffolds were 
prepared by the polymerization of an NT3/PDGF-polymer solution mixed with stem-cell derived 
neural progenitor cells. The presence of viable cells inside the tri-dimensional structure was 
confirmed, resulting in enhanced differentiation level of the cells into neurons due to the presence 
of NT3 and PDGF. In this study, the receptors for epidermal growth factor were neutralized by 
the addition of a blocking antibody to the structure, thus blocking the inhibitory pathways present 
in an injured area. Core shell fibers have also been used to deliver NGF for sciatic nerve 
regeneration in rats. NGF was loaded in the PEG core of the fiber, which was covered by a 
PLGA shell. After initial release of the NGF that migrated to the shell during the electrospinning 
process, NGF release was mainly due to diffusion through the shell layer, hence reducing the 
initial burst phenomenon. Grafting of this conduit for nerve guidance promoted functional 
recovery with the same efficiency as autografts 12 weeks after implantation. [40] A very similar 
technique has been used to deliver VEGF using coaxially electrospun fibers of hydroxyl-
functionalized poly(ε-caprolactone) as a shell and VEGF-loaded BSA as a core. [41] 
Erythropoietin was delivered at stroke site using hyaluronan/methyl cellulose (HAMC) hydrogel. 
The latter was chosen based on its anti-inflammatory properties, mostly attributed to the presence 
of hyaluronan. Erythropoietin diffused from the implant to the ventricular zone of the stroke, 
reducing the cavity, and proved to have neuroprotective and neurogenerative properties. [42] 
Another advantage of this process may reside in its applicability to perform growth factor 
gradients. This aspect is particularly appealing since, in the adult nervous system, stem cells 
migrate to their final location by following growth factor gradients that are present in the tissue. 
[43-45] Axons are also known to grow along these gradients. More importantly, these gradients 
have an influence on the differentiation pathway followed by the cells. [46] Therefore, attempts 
have been made to mimic these natural gradients to spatially localize neurogenesis. [47] Growth 
factor gradients have been created either by assembling hydrogel pieces filled with growth factors 
at various concentrations [48] or by growth factor diffusion from wells being positioned within 
the hydrogel so as to result in the establishment of a gradient upon diffusion. [49] It was shown 
that gradients of the neurotrophic factors NGF and B27 used synergistically could multiply and 
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position synapses within the construct. [50] The gradients were created using channels connected 
with PDMS reservoirs that were filled at different time points to create a diffusion gradient. The 
synapse density increased proportionally with the NGF/B27 gradients.  
 
2.3.3 Delivery of encapsulated growth factors to the native tissue 
Scaffolds could also be applied to the delivery of growth factors in situ without any scaffold 
colonization by endogenous cells; the structure being used as a reservoir only. This use is 
believed to be of particular interest in the case of Alzheimer's disease where the patient is unable 
to maintain the adequate population of cholinergic neurons. That is, since NGF is a growth factor 
that stimulates the cholinergic function, its delivery to the brain of patients suffering from 
Alzheimer's disease has been investigated. In this specific case, the NGF be delivered passed the 
blood brain barrier, and the delivery must be very local to avoid any other regions of the brain to 
be impacted. Therefore, polymeric devices have been investigated to deliver NGF locally in rat 
brains. [51,52] While local delivery was successful, remaining limitations were the short half-life 
of those molecules and the short migration distance, hence the importance of the choice of the 
implantation site. [51,53] BDNF delivery, via hydrogels implanted into rat brains has also been 
investigated as BDNF could be used to treat major depression. In these studies, BDNF delivery 
was found to be successful as an antidepressant effect was observed. Once again, the efficacy of 
the treatment is closely related to the concentration of growth factors that reaches the targeted 
cells and the duration of the treatment. [54] 
 
2.3.4 Use of cells to produce and deliver growth factors in situ 
As emphasized in the preceding section, growth factor delivery is associated with many hurdles 
related to adequate spatio-temporal delivery. In order to overcome these issues, in situ synthesis 
of instructive cues by encapsulated cells has been investigated. In that respect, Shanbhag and 
colleagues encapsulated two lines of fibroblasts being genetically modified to produce either 
BDNF or NT-3. [55] The cell-containing scaffolds were demonstrated to enhance cell survival, 
migration distance of NPCs, and NPCs attachment to the scaffold as well as better survival when 
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compared to empty scaffolds. NT-3 secretion by modified fibroblasts was shown to promote 
neuron formation. In their study, Dey and colleagues injected MSCs genetically engineered to 
secrete BDNF or NGF in YAC 128 mice (a model for Huntington’s disease) and measured mice 
motor abilities. [56] MSCs secretion of BDNF improved neuronal survival and reduced clasping 
and behavioral deterioration after 9 months. Those results were not observed with NGF-
producing MSCs or with pristine MSCs, although mice that had received unaltered MSCs also 
presented less clasping. This result was attributed to the secretion of anti-inflammatory cytokines 
by the injected MSCs, once again highlighting the advantages of MSC manipulation for this 
application. Such a strategy may however be inapplicable due to serious ethical concern.  
Cells may also be used as an underlying layer to provide a favorable environment to regenerate 
neuronal structures ex vivo. The experimental approach would then rely on culturing a first layer 
of cells on top of which the cells of interest would grow. The first cell layer would provide 
trophic factor(s) to create a niche where the neuronal cells could optimally develop. In that 
endeavor, the use of a PA6 cell layer (a bone marrow-derived stromal cell line, precursor of 
adipocytes) was shown to provide an excellent environment in which human embryonic stem 
cells were able to differentiate in vitro into dopaminergic neurons in a highly specific way (87 
%), prior to injection. [57] The exact role of PA6 cells was not fully understood, and was partly 
attributed to uncharacterized growth factors production. This technique has also been used to 
deliver growth factors to other cells directly inside the brain: NGF producing fibroblasts were 
implanted into the forebrains of six patients suffering from Alzheimer's and resulted in significant 
neuronal growth and slowed down the cognitive decline. [62] 
 
2.4 Use of structures to mechanically support tissue growth 
As discussed above, both stem cells and growth factors have shown promising results but their 
immediate use still presents limitations that prevent their routine implementation to the clinic. 
While injections of cells and/or growth factors promote tissue regeneration, a structure that offers 
an adequate mechanical support for the growth of endogenous or injected cells may be required 
when the injury site is large. [58] Filling the injury cavity with a mechanically relevant scaffold 
may prevent the formation of scar tissue; the latter being known as a hostile environment for 
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neurite growth due to its inherent structure and the presence of macrophages and other inhibitory 
factors. [59] Furthermore, in the case of neurodegenerative diseases, the pathological tissue is no 
longer able to adequately present the factors promoting proper differentiation of injected stem 
cells, as already observed when stem cells were injected to treat Alzheimer's disease. [13] [60] A 
scaffold that would support cell growth and differentiation, offering a protective and stimulating 
microenvironment may thus be required since the host tissue is no longer able to play that role. 
 
2.4.1 Hydrogels to offer mechanical support to cells 
Hydrogels (Figure 1) have now emerged as a type of materials of choice for implant design. 
Hydrogels are usually defined as water-swollen polymer networks, often resulting from the 
polymerization of hydrophilic polymers. Such polymerization can be chemically driven, through 
reaction with a crosslinker, [61] or physically driven, through a change in reactivity or 
conformation that may be induced by pH or temperature changes [62] or even photo-activated. 
[63] Physically crosslinked hydrogels have the potential to be generated directly in situ; they do 
not require the use of photo-crosslinkers that are often toxic. However, these hydrogels are 
usually less stable than their chemically crosslinked counterparts. [62] Hydrogels present many 
advantages for neural tissue regeneration, as it is relatively easy to create a three-dimensional 
hydrogel structure harboring adequate mechanical properties. Furthermore, the inherent 
hydrophilicity of hydrogels - along with their ability to deliver growth factors - make them good 
candidates for neural cell supportive systems. [64] Amongst them, several polysaccharides 
including agarose, alginate, methylcellulose, dextran and chitosan as well as polysaccharide 
blends have been investigated. Soft, positively charged surfaces as those obtained with 
dextran/chitosan blends were reported to favor neuron attachment by Zudema and colleagues. 
[65] Hyaluronic acid (HA) was also reported to offer adequate mechanical support as well as 
good cell adhesion, proliferation and migration properties. [35]  
The fact that physiological fluids penetrate hydrogels, combined to their softness and their three-
dimensional structures, make them interesting candidates for tissue repair. As already 
demonstrated for vascular repair applications, hydrogels per se are presented by some authors as 
sufficient to allow neuronal cell growth and tissue formation. [66] On the same note, 
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differentiation of NSCs has been observed in three-dimensional porous chitosan scaffolds. On 
their own, these scaffolds were shown to promote differentiation to a higher extend than when 
soluble NGF was administered to cells cultured on two-dimension surfaces; the combination of 
three-dimensional scaffold with NGF however gave the best results. [67] The modulus of 
hydrogels was shown to be a critical parameter: for alginate-based constructs, a lower stiffness 
was reported to lead to better proliferation and differentiation of NSCs.  [68] 
Hydrogels have already been tested several times in animal models in vivo animal models for 
neuronal regeneration. [69-72] Their healing properties have been assayed when used as bridges 
after spinal cord or nerve sectioning. In such assays, Poly[N-(2-hydroxypropyl) methacrylamide] 
(PHPMA) hydrogels were successfully used in rats with sectioned spinal cord. [73] PHPMA 
constructs were reported to be well integrated, to prevent scar tissue formation and to promote 
axonal colonization. Such success was attributed to the good swelling and elastic properties of 
this type of hydrogels, combined to their high porosity that allowed neuronal and axonal growth 
through the structure. [73]  
 
Fig 1. Hydrogel fabrication and application 
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2.4.2 Electrospun fibers as a mechanical support for cell development 
Another fabrication technique, namely electrospinning, has also been demonstrated to be 
successful for the generation of three-dimensional scaffolds made of micro- to nano- size fibers 
with controlled properties. This technique was originally developed to create textiles and filters 
and was then prop osed for wound dressing material. [74] In this process, a polymer solution is 
pushed through a metallic needle (Figure 2) while a strong electric field is imposed between the 
needle and the collector, charging the surface of the droplet at the extremity of the needle with 
static electricity (Figure 3). The polymer solution is then attracted by the electric field, and forms 
nanofibers (200-1500 nm of diameter) that dry during their flight between the needle and the 
collector. [75] This method is well adapted for neuronal scaffold production as fibrous scaffolds 
with high surface-to-volume ratios and structurally mimicking the extracellular matrix can be 
generated. [76] Furthermore, various polymers of interest, including biodegradable ones, can be 
used to create electrospun fibers. Those include poly lactic acid (PLLA), poly glycolic acid 
(PGA) and their copolymers, PLGA, poly(ether sulfone) (PES). [77-80] This high flexibility in 
terms of material selection, fiber diameter and orientation, porosity and mechanical properties 
offers a wide choice of possibilities so that biocompatible mats with adequate degradation rate 
and mechanical properties can be designed. [81] Examples are given in Table 2. 
 
 
 
 
 
 
 
 
Fig 2. Co-electrospinning needles: device allowing electrospinning of 3 different solutions with 
a layered core shell structure (A). Needles used with this core shell structure. (B) Diameters are 
respectively 1.83 and 3mm. 
 
B A 
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Fig 3. Electrospinning setup 
Christopherson and coworkers investigated the influence of electrospun fiber diameter on rat 
NSCs, while the cells were cultured on PES fibers coated with laminin for cell attachment. [82] 
Of interest, different phenotypes were obtained with different types of fibers: fibers of small 
diameter (283 nm) were shown to promote NSCs differentiation into oligodendrocytes whereas 
larger fibers (749-nm diameter) promoted their differentiation into neurons. Wang et al. also 
showed that aligned tussah silk fibroin (TSF) fibers had a significant beneficial effect on neural 
differentiation of hESC. [83] They demonstrated cell migration along the fibers, and neurite 
growth with neurites following the fiber direction. In comparison, the cells cultured on random 
fibers migrated randomly with a shorter migration range. Neurites were longer on 400-nm 
aligned fibers, when compared to 800-nm ones. The authors nevertheless mentioned that, in some 
experiments, neurites happened to grow perpendicularly to fiber direction. They showed a 6% 
increase in the neuron amount on 400-nm aligned nanofibers when compared to 800-nm aligned 
fibers. Altogether, neurites were significantly longer and followed the material direction. In 
comparison, 800-nm random fibers showed a decrease both in number and total neurite length.  
Lower cell migration and proliferation were observed on these structures when compared to 2-D 
culture conditions. Cells were also shown to grow towards the fiber pattern: the thinner fibers 
directed the elongation of the cells, most likely explaining the increased level of differentiation 
into neurons. Of interest, cell culture on PLLA fibers was reported to abrogate the need of calf 
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serum in the culture medium. In the absence of calf serum, neurite alignment was increased. [84] 
Finally, the implantation of these structures in the area of sectioned nerves or degenerated tissues, 
as a support for the re-growth of host tissue, has been investigated. Nisbet et al. implanted 
electrospun fibers of poly(ε-caprolactone) in rat brains. [85] 60 days after implantation, scaffolds 
were not encapsulated in scar tissue, despite a recruitment of microglia and astrocytes. The 
structure promoted tissue growth as demonstrated by the presence of neurites inside the construct. 
Intriguingly, cell growth occurred perpendicular to fibers rather than in a parallel direction and 
randomly aligned fibers showed a better colonization by endogenous cells. The first observation 
was contradictory to experiments performed in vitro; further investigation is thus required to 
better understand and master this therapeutic approach.  
 
Co-electrospinning may answer the dual needs of controlling the porosity and mechanical 
properties of materials, as well as allow drug delivery abilities of materials created with other 
techniques. In this approach, a core shell structure is created using a double coaxial needle. The 
core is made of the same polymeric materials as previously evoked. The outer part can be made 
of various materials such as laminin, which has been shown to favor cell attachment to the fibers. 
[86] Other proteins such as gelatin may also be used. [87] In such system, the core brings 
porosity and stiffness while the outer part of the fiber allows for a receptive contact of the cells 
on the scaffold surface; the outer layer may also be used for in situ growth factor delivery. As an 
alternative to co-electrospinning, electrospun fiber modification by hydrogel polymerization may 
be applied to create an outer shell to enhance cell contacts. Using this approach, Poly(ε-
caprolactone) electrospun fibers were covered with poly(ethylene glycol)-poly(ε-caprolactone) 
(PEGPCL) hydrogel, to support neural growth and deliver NGF in situ. [88] This construct was 
used to coat implanted electrodes. The mechanical support offered by the fibers reduced the 
degradation rate of the hydrogel, resulting in the elution of NGF, which increased the proximity 
of neurons and electrodes. An interesting technique has been developed by Huang et al. who 
electrospun fibers through a hole in a charged mask to create fiber patterns. Using this technique, 
fibers were patterned on a cell repellant hydrogel; regulating the voltage applied to the mask 
controlled the size and density of the fiber spots. This technique opens new avenues to control 
cell colonization through the creation of cell-receptive or -repulsive areas. [89] 
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Hydrogels and electrospun fibers have thus been demonstrated to favor stem cell growth and 
differentiation without any addition of growth factors; a very appealing property for the treatment 
of nerve injuries. However, in the case of degenerative diseases, the patient’s cells are usually 
unable to produce the required set of growth factors promoting regeneration; their inclusion in the 
implanted scaffold may thus be mandatory. Those factors may also be needed to counter the 
effects of molecules promoting the disease or, simply to promote the growth of functional tissue. 
[13] In addition to appropriate growth factor inclusion within a given scaffold, providing healthy 
stem cells to create tissue with restored functions may be desirable, as endogenous cells have lost 
this ability. 
 
2.4.3 Use of structures to display bound growth factors in situ 
As an alternative to growth factor diffusion from hydrogels or release from electrospun 
structures, growth factor immobilization through covalent grafting or non-covalent but stable 
tethering, has also been reported for both hydrogels and electrospun fibers. Covalent grafting of 
integrin binding peptides inside a collagen structure has been shown to enhance cell attachment 
to the substrate and improve cell viability [90]. Also, the stable tethering of BDNF onto collagen 
scaffold has also been assayed. The latter was achieved by designing a chimeric protein 
corresponding to BDNF fused to collagen binding domain. Scaffolds decorated with chimeric 
BDNF and seeded with dorsal root ganglia cells were implanted in rats and resulted in good 
recovery after spinal cord transection. [91] On the same note, the production of EGF fused to 
collagen binding domain has also been documented; its use for stem cells encapsulation within 
EGF-decorated collagen-based hydrogel resulted in better cell survival than in control collagen 
scaffold, while cells were observed to differentiate into various neural phenotypes. [92] Human 
recombinant BDNF and human recombinant NT-3 were also covalently immobilized on gelatin-
based scaffolds using photo-polymerization: photocurable styrene derivatized gelatin was used to 
produce conduits on which extracellular matrix molecules along with rhBDNF and rhNT-3 were 
photo-co-immobilized. Dorsal root ganglia showed larger neurite extensions on structures 
displaying both neurotrophins than on structures displaying only one of the two proteins. [93] 
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NGF immobilization on chitosan scaffolds using genipin crosslinking was also applied to 
generate conduits later implanted in denervated rats. Such strategy was shown to lead to nerve 
reconstruction in vivo. [94]  
Electrospun fibers were also used as displaying structures. [95] Amine terminated poly(ethylene 
glycol) and poly(ε-caprolactone) allowed Cho and colleagues to prepare amine functionalized 
electrospun fibers on which NGF was subsequently grafted. This strategy permitted to eliminate 
initial burst in released molecules, while increasing cell differentiation into neurons. Of salient 
interest, growth factor immobilization onto fibers led to more pronounced results than those 
related to cell culture on fibers in the presence of soluble cues. [96] In another work, covalent 
grafting of BDNF was performed on ethylene diamine-modified poly(ε-caprolactone) fibers. 
Cells proliferated more on these displaying structures even with half the amount of soluble 
BDNF. [97] 
Spatially varying growth factor density during immobilization may also be of interest to explore 
the potential benefits of gradients of non-diffusible growth factor(s). This may be achieved 
thanks to recent technical developments now allowing for the creation of patterns of non-
diffusible proteins: in that respect, laser-assisted protein adsorption by photobleaching is 
extremely promising. [98] 
 
2.4.4 Use of anisotropic scaffolds to direct tissue growth 
A desirable feature for smart engineered grafts would be to mimic patient’s tissue spatial 
organization in order to direct tissue regeneration, as nerve regeneration implies that new axons 
grow in the same direction. As previously mentioned, in order to meet this goal, growth factor 
gradients have been proposed, since they are responsible in vivo for directing the genesis of 
endogenous tissues. However, several attempts to create such gradients highlighted technical 
difficulties. [43-45] Therefore, as an alternative, the use of hydrogel- or electrospun fiber-based 
anisotropic scaffolds has been explored. Most hydrogels are obtained from the polymerization of 
monomers in solution and therefore show isotropy. Although this fabrication process is not 
adapted to generate structure determinism, hydrogels made of apo-collagen bear the potential to 
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be shaped to form aligned structures and membranes. [99] These structures, designated as linear 
ordered collagen scaffolds, were crosslinked with laminin to direct axon growth. [100] 
Implantation of this material allowed functional recovery in rats, with improved linear orientation 
of the newly generated tissue. 
When topology needs to be controlled, electrospinning appears as the method of choice since the 
extent to which fibers are aligned can be varied with mandrel rotating speed. Electrospun fiber 
structures have been demonstrated to be extremely promising to direct axons growth and model 
newly grown tissue. In a previously evoked study, aligned PLLA fibers were used to grow motor 
and sensory neurons. Neurons were shown to grow following nano-fiber orientation and neurites 
grew along the fibers. [84] Aligned electrospun fiber structures may thus be a key to direct axonal 
growth and cell migration. [101]  
 
2.5 Use of conductive structures to electrically stimulate neuron 
differentiation 
The neural tissue is electrically active, therefore attempts have been made to create conductive 
structures to allow electrical stimulation of the cells in order to improve the functionality of the 
graft. Cells that had been stimulated on a cover glass coated with conductive gold nanoparticles 
showed an increase in neurite length. [102] The design of a 3-D conductive scaffold made of 
freeze-dried collagen with polypyrrole, and presenting oriented micro channels has been reported. 
Electrical stimulation thanks to this structure increased neurite outgrowth in the direction of the 
electrical field in vitro and resulted in a better remyelination of the axons while Schwann cells 
were observed to migrate towards the anode. [103] In the case of electrospun fibers, conductivity 
may be obtained through the use of polypyrrole in the fiber core or as an outer layer being 
polymerized on electrospun fibers. [104] 
Conductive electrospun nanofibers were also proved to enhance the rate of neurite growth and 
their total length. [105] When polypyrrole was polymerized onto PLA and PLGA electrospun 
fibers, the resulting structure was shown to be effective for dorsal root ganglia cell culture. 
Electrical stimulation resulted in 40% longer neurites. [105, 106] NGF has been incorporated in 
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such conductive constructs, in order to benefit from the growth factor effect as well as the 
stimulation. Longer neurites were obtained using this combination. [107]  
Another way to add conductive properties to materials is to include carbon nanotubes or 
nanoparticles in the structure. [108] Carbon nanotube-mediated electrical stimulation was shown 
to promote neural maturity, and increase the speed of neurite outgrowth. [109] Carbon nanotubes 
were integrated in PLA electrospun fibers and conferred conductive properties. [110] Electrical 
stimulation resulted in increased levels of neuronal markers and stimulated neurons were more 
aligned along fibers. A difficulty for the use of nanotubes in electrospinning is the difficulty to 
spin them directly. To overcome this issue, Miao et al. co-electrospun multi-walled carbon 
nanotubes and poly(vinyl pyrrolidone) using co-axial electrospinning. The core of the fibers was 
composed of nanotubes while the sheath was made of poly(vinyl pyrrolidone) as a way to make 
the nanotube solution spinnable. [111]  
Finally, carbon nanotubes can be used alone as conductive cell support. The main issue resides in 
their toxicity; their biofunctionalization is thus required. [112] NSCs were cultured on nano-ropes 
of carbon nanotubes: the structure strongly increased the maturation of NSCs into neuronal cells 
and promoted neurite elongation following the topography of the rope. [113]  
 
2.6 Conclusion 
Current techniques and strategies that may allow for neuronal tissue regeneration or replacement 
were reviewed. While stem cell injection was proven to promote functional recovery, it is now 
accepted that the effect is mainly due to growth factors and other instructive cues being secreted 
by these cells rather than injected cells differentiating into new tissue. These growth factors may 
thus be injected directly in situ to reach similar results, however, this requires heavy surgery. 
Their release from a scaffold implanted in the diseased area though diffusion or degradation, or 
alternatively, their attachment to an implantable scaffold, has been investigated with some 
noticeable success. Such a strategy is very attractive as it decreases the amount of growth factor 
needed and limits their effect to the injured area while taking advantage of the mechanical 
support provided by the scaffold itself.  
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Altogether, ideal nervous or neuronal implants should present several characteristics. The 
literature is now consensual upon the fact that, for an implant, mimicking the extracellular matrix 
features including porosity, pore size, and mechanical properties, while acting as a reservoir of 
instructive cues and harboring adequate topology for an appropriate spatial organization of the 
tissue, are all desirable traits. Therefore, despite all promising results presented therein, a 
significant amount of work remains to be done in order to fulfill all those requirements and 
enable the long-term success of regenerative medicine approaches. Above all, any technique 
should cope with surgeons’ constraints. In that endeavor, hydrogels present several interesting 
features as they are well characterized, commonly used as drug carriers, and since they can be 
prepared with a variety of chemicals. Also, as an alternative, electrospinning was proven to be 
very promising as it permits to control the mechanical properties of the scaffold while designing 
conductive materials. Alignment of fibers and incorporation of growth factors were also shown to 
be feasible for additional tailoring of electrospun scaffold, i.e., to direct tissue growth and control 
cell phenotype. Many other materials may also lead to the development of constructs with 
improved  regenerative potential: polyurea silica aerogels, [114] phosphate-based glass fibers 
[115], to name a few, are indeed amenable to produce scaffolds with interesting properties 
regarding their biocompatibility, nano-porous structure, mechanical strength, directionality or 
surface functionalization. Matrigel, which is made of extracellular proteins secreted by 
Engelbreth-Holm-Swarm (EHS) mouse sarcoma that easily self assemble to form a matrix, has 
been assayed to regenerate nerve tissue and gave good results regarding the differentiation of 
dopaminergic neurons. [116] Finally, self-assembled fibers made of spider silk have been 
reported to spatially support neuronal and astrocytic differentiation. [117] [118]Scaffold design 
could also benefit from a other fabrication techniques such as oriented growth factors 
immobilization strategies [119] , layer-by-layer lithography [120], microcontact [121] [122] or 
inkjet printing [123] [124] to give a few examples of very promising approaches being currently 
explored. Finally, recent research is now pointing towards alternatives to electrical stimulation to 
promote cell differentiation: sub sonic vibrations [125], stretching [126], cyclic tensile loading 
[127] and low level LASER (LLL) stimulation [128] are promising avenues that may impact 
significantly future research in neural regeneration. 
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Table 1. Growth factors and their use in the context of neuronal disease treatment 
Growth factor Effect 
Enhanced Phenotype / 
Pathway 
Delivery 
technique 
Species Ref 
BDNF 
Increases number of 
neurons in striatum, 
septum, thalamus and 
hypothalamus 
N/A Intraventricular 
administration  
Rat [129] 
Promotes myelinisation, 
prevents migration 
TrkB and p75 pathways for 
cell death, Rho kinase for 
migration 
Injection Rat [130] 
GDNF 
Regulates proliferation, 
differentiation and 
survival of neurons 
Pathways associated to Ret 
and GDNF family receptor 
α1 (GFR α1), on the surface 
of migrating enteric neural 
crest–derived cells 
N/A Chick [131] 
Erythropoietin  
Prevents apoptosis, anti-
oxydant, promotes 
differentiation into 
dopaminergic neurons 
Mimics lower O2 
environment 
Addition to the 
medium, in 
vitro  
Rat [132] 
EGF 
Enhances NSC 
proliferation 
Neural stem cell Released from 
implanted 
hydrogel 
Mouse [133] 
FGF-2 
Maintains cell viability, 
increases cell 
proliferation 
N/A Addition to the 
medium, in 
vitro 
Rat [82] 
FGF-4 
Promotes serotoninergic 
differentiation 
N/A Addition to the 
medium, in 
vitro 
Rat [134] 
FGF-8 
 
Promotes dopaminergic 
and serotoninergic 
differentiation 
Effect on antero posterior 
position 
Addition to the 
medium, in 
vitro 
Rat [134] 
Mitogen, promotes 
differentiation into 
mesencephalic precursors 
Effect on antero posterior 
position 
Addition to the 
medium, in 
vitro 
Rat [132] 
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Table 1. Growth factors and their use in the context of neuronal disease treatment (continues) 
Growth factor Effect 
Enhanced Phenotype / 
Pathway 
Delivery 
technique 
Species Ref 
Growth 
differentiation 
factor 5 (TGF-β) 
Prevents apoptosis, 
neurotrophic and 
neuroprotective effects 
on dopaminergic neurons 
Pathways involves 
serine/theronine kinase 
receptors, BMPs 
Intracerebral 
injection 
Human [130] 
IGF-1 
 
Promotes differentiation 
into oligodendrocytes 
Inhibition of BMP signaling Injection  Rat [135] 
Protects motor neurons, 
inhibit cell death 
MAPK and PI-3K pathways Addition to the 
medium, in 
vitro 
Rat [136] 
Increases cell survival, 
protects cells from 
epoxomicin effects and 
from apoptosis 
Activation of PI3/AKT 
pathways, reduce cytochrome 
c release 
Addition to the 
medium, in 
vitro 
Human 
(SH-
SY5Y) 
[137] 
Interleukin 1-6 
Promotes neuronal 
survival, protects against 
damage, induces 
neuronal differentiation, 
stimulates astrocyte 
proliferation 
Interleukin receptor N/A Rat [138] 
Mash-1 
Promotes neural 
proliferation and 
differentiation  
X-Notch-1 receptors N/A Rat [139] 
Neurogenin1 -2 
Required for dorsal root 
ganglia development 
trkC+ and trkB+ neurons 
(ngn2) 
trkA+ (ngn1) 
Knock-out 
manipulations 
Mouse [140] 
Neuroreguline 
1β 
Regulates outgrowth of 
neurites 
erbB receptors 
phosphatidylinositol 3-kinase 
(PI3K) 
Addition to the 
medium, in 
vitro 
Rat [141] 
Neurturin 
(NTN) 
Helps survival and 
neuritogenic factor 
GDNF family receptor 
(GFR) α-2 and signal 
transducing receptor kinase 
Ret 
Injection  Rat [130] 
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Table 1. Growth factors and their use in the context of neuronal disease treatment (continues) 
Growth factor Effect 
Enhanced Phenotype / 
Pathway 
Delivery 
technique 
Species ref 
NGF 
Promotes choline 
acetyltransferase in 
forebrain 
ChAt (motoneurons) Injection Human [129] 
Retinoic Acid 
Promotes differentiation 
into neurons 
N/A Addition to the 
medium, in vitro 
Rat [82] 
Promotes differentiation 
into oligodendrocyte 
N/A Addition to the 
medium, in vitro 
Rat [142] 
Shh  
Promotes differentiation 
into motoneurons 
Ventralization Injection of shh 
releasing 
microspheres 
Mouse [143] 
TGF-α 
 
Stimulates proliferation EGF receptor N/A Mouse [144] 
Promotes dopaminergic 
differentiation, mitogen 
for cells of ectodermal 
and mesodermal origin, 
induces neurite 
outgrowth 
EGF receptor In vitro 
induction  
Human [145] 
VEGF Prevents inflammation, 
secondary degeneration 
Reduces leukocyte 
infiltration and microglial 
activation, suppresses 
inflammatory cytokines 
In vivo delivery 
using an 
implanted 
cannula 
Mouse [146] 
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Table 2. Examples of tri-dimensional scaffolds generated by electrospinning 
Material Solvent Porosity  Mechanical 
characterization 
Bioproperty  Conductivity Ref 
 
Chitosan/polyethylene 
oxyde 
Acetic acid 70% Tensile strengh 
4MPa, modulus 
147 MPa 
Non toxic, 
nonantigenic 
(chitosan’s 
properties) 
10
−7
 S/cm     
[147] 
 
poly(ethersulfone) 
 
DMF/Toluene 71%   N/A     
[80] 
 
 
 
Poly(ε-caprolactone) 
 
1:1 
tetrahydrofura
n and N,N-
dimethylforma
mide 
90% Tensile modulus : 
5.0 ± 0.7 MPa, 
yield stress : 0.55 
± 0.06 MPa 
Non toxic 
by-products 
N/A     
[148] 
chloroform 90% Tensile modulus : 
6.4 ± 0.2 MPa, 
yield stress  0.55 
± 0.06 MPa 
Non toxic 
by-products 
0.0015 
S · cm−1 
    
[148, 
149] 
 
polyurethane/collagen 
1,1,1,3,3,3,-
hexafluoro-2-
propanol 
62-71% Tensile stress 
4.53MPa 
Cell adherent, 
biodegradable 
N/A     
[150] 
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Table 2. Examples of tri-dimensional scaffolds generated by electrospinning (continues) 
Material Solvent Porosity  Mechanical 
characterization 
Bioproperty  Conductivity Ref 
 
 
 
poly(lactide-co-
glycolide) 
 
Dichlorometha
ne +N,N-
dimethyl 
formamide 
(9:1) 
75% Young modulus 
134MPa (40 MPA 
for aligned fibers) 
Biocompatible 
and 
biodegradable 
Interesting 
mechanical 
properties but 
no cell 
recognition 
site 
N/A     
[79] 
 
 
poly(L-lactic acid) 
1,1,1,3,3,3-
hexafluoro-2-
propanol 
71%   N/A     
[77] 
2,2,2-
trifluoroethano
l (TFE) 
Pore size 
: 4.51 
µm 
Tensile strength 
0.063MPa,  
young’s modulus 
0.41MPa 
 
N/A     
[151] 
Polyaniline/ 
camphorsulfonic acid 
/gelatin 
1,1,1,3,3,3-
hexafluoro-2-
Propanol 
 Modulus 614 
MPa 
Conductive : 
allows 
electrical 
stimulation 
0.01-0.021 
S/cm 
    
[152] 
polyvinylidene 
fluoride–
trifluoroethylene 
methyl ethyl 
ketone 
43-80% N/A Piezoelectric 
: stimulates 
neurons, 
neurite 
elongation 
N/A     
[153] 
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Table 3. Examples of techniques tested in vivo 
 
 Substance 
delivered 
Advantages Inconvenients Species Ref 
 
 
 
Injection of 
Growth factors 
Erythropoietin Enhances nerve recovery, 
effect on muscle 
regeneration 
Single injection, no 
duration, effect on 
muscle regeneration 
rat [153] 
IGF-1, IGF-2 Promotes intramuscular 
nerve sprouting 
Immunoreactivity 
and proliferation of 
interstitial cells 
Rat, mouse [155] 
BDNF, CNTF Enhances survival Effective only 
before the 5
th
 or 7
th
 
week. 
rat [156] 
 
Injection of 
recombinant 
genes 
NGF-β gene Enhances survival and 
neurite outgrowth, frees 
from the numerous 
injections of GF 
Gene manipulation 
: use of an 
adenovirus, can be 
expressed in the 
liver, need longer 
investigation 
rat [157] 
 
Injection of cells 
MSCs Support axonal regrowth 
by producing growth 
factors 
Huge variability in 
effects (length of 
the axons) 
rat [158] 
 
Injection of cells 
and growth 
factors 
Bone marrow 
stromal cells and 
granulocyte 
colony-
stimulating factor 
Significant functional 
recovery, smaller scar, 
reduced apoptosis, 
differentiation into CD-4+ 
cells 
Needs 
improvement, 
involves several 
injections of growth 
factor 
rat [159] 
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Table 3. Examples of techniques tested in vivo (continues) 
 
 Substance 
delivered 
Advantages Inconvenients Species Ref 
Implantation of 
artificial matrix 
for cell support 
Polyamidoamine 
hydrogel 
Facilitates nerve 
regeneration, functional 
recovery, no inflammation, 
biodegradability, 
biocompatibility 
permeability, non 
immunogenicity, 
mechanical strength 
Degradation time rat [160] 
Implantation of 
supportive 
structure (growth 
factor delivery 
system) 
Neurotrophin-3 
and 
chondroitinase 
ABC on 
electrospun 
collagen 
Improves efficacy of the 
structure, no repeated 
injections of growth 
factors 
Fast release at the 
beginning 
In vitro [161] 
 
 
 
BDNF in agarose 
hydrogel 
Fills irregular defects in 
injured spinal cord, 
prevents inflammatory 
response, delivers BDNF 
in situ 
Study with cells is 
needed 
rat [162] 
Hyalorunic acid 
hydrogel 
containing BDNF 
Locomotor function 
recovery, prevents 
inflammation 
Study with cells is 
needed 
rat     [163] 
 
 
32 
 
 
2.7 Bibliography 
[6] A. Di Carlo, "Human and economic burden of stroke," Age and ageing, vol. 38, pp. 4-5, 
Jan 2009. 
[7] "Spinal cord injury facts and figures at a glance," The journal of spinal cord medicine, 
vol. 35, pp. 480-1, Nov 2012. 
[8] B. Ford. (2010). Parkinson's Disease Q & A, Sixth Edition.  
[9] M. May, S. M. Sobol, and S. J. Mester, "Hypoglossal-facial nerve interpositional-jump 
graft for facial reanimation without tongue atrophy," Otolaryngology--head and neck 
surgery : official journal of American Academy of Otolaryngology-Head and Neck 
Surgery, vol. 104, pp. 818-25, Jun 1991. 
[10] D. N. Brooks, R. V. Weber, J. D. Chao, B. D. Rinker, J. Zoldos, M. R. Robichaux, S. B. 
Ruggeri, K. A. Anderson, E. E. Bonatz, S. M. Wisotsky, M. S. Cho, C. Wilson, E. O. 
Cooper, J. V. Ingari, B. Safa, B. M. Parrett, and G. M. Buncke, "Processed nerve 
allografts for peripheral nerve reconstruction: a multicenter study of utilization and 
outcomes in sensory, mixed, and motor nerve reconstructions," Microsurgery, vol. 32, pp. 
1-14, Jan 2012. 
[11] A. L. Dellon and S. E. Mackinnon, "An alternative to the classical nerve graft for the 
management of the short nerve gap," Plastic and reconstructive surgery, vol. 82, pp. 849-
56, Nov 1988. 
[12] J. L. Montastruc, O. Rascol, and J. M. Senard, "Treatment of Parkinson's disease should 
begin with a dopamine agonist," Movement Disorders, vol. 14, pp. 725-730, Sep 1999. 
[13] K. Sugaya and S. Merchant, "How to approach Alzheimer's disease therapy using stem 
cell technologies," Journal of Alzheimer's disease : JAD, vol. 15, pp. 241-54, Oct 2008. 
[14] R. H. Miller, "The promise of stem cells for neural repair," Brain research, vol. 1091, pp. 
258-64, May 26 2006. 
[15] W. Hwang, A. Alvarez-Buylla, and D. Lim, "Glial Nature of Adult Neural Stem Cells: 
Neurogenic Competence in Adult Astrocytes," in Neural Development and Stem Cells, M. 
33 
 
 
S. Rao, M. Carpenter, and M. C. Vemuri, Eds., ed: Springer New York, 2012, pp. 149-
172. 
[16] J. A. Pawitan, "Prospect of cell therapy for Parkinson's disease," Anatomy & cell biology, 
vol. 44, pp. 256-64, Dec 2011. 
[17] N. Joyce, G. Annett, L. Wirthlin, S. Olson, G. Bauer, and J. A. Nolta, "Mesenchymal stem 
cells for the treatment of neurodegenerative disease," Regenerative medicine, vol. 5, pp. 
933-46, Nov 2010. 
[18] I. Kassis, N. Grigoriadis, B. Gowda-Kurkalli, R. Mizrachi-Kol, T. Ben-Hur, S. Slavin, O. 
Abramsky, and D. Karussis, "Neuroprotection and immunomodulation with mesenchymal 
stem cells in chronic experimental autoimmune encephalomyelitis," Archives of 
neurology, vol. 65, pp. 753-61, Jun 2008. 
[19] I. Aizman, C. C. Tate, M. McGrogan, and C. C. Case, "Extracellular Matrix Produced by 
Bone Marrow Stromal Cells and by Their Derivative, SB623 Cells, Supports Neural Cell 
Growth," Journal of Neuroscience Research, vol. 87, pp. 3198-3206, Nov 1 2009. 
[20] B. J. Cummings, N. Uchida, S. J. Tamaki, D. L. Salazar, M. Hooshmand, R. Summers, F. 
H. Gage, and A. J. Anderson, "Human neural stem cells differentiate and promote 
locomotor recovery in spinal cord-injured mice," Proceedings of the National Academy of 
Sciences of the United States of America, vol. 102, pp. 14069-74, Sep 27 2005. 
[21] C. V. Borlongan, Y. Tajima, J. Q. Trojanowski, V. M. Lee, and P. R. Sanberg, 
"Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N 
cells) promotes functional recovery in ischemic rats," Experimental neurology, vol. 149, 
pp. 310-21, Feb 1998. 
[22] W. Heine, K. Conant, J. W. Griffin, and A. Hoke, "Transplanted neural stem cells 
promote axonal regeneration through chronically denervated peripheral nerves," 
Experimental neurology, vol. 189, pp. 231-40, Oct 2004. 
[23] J. R. Munoz, B. R. Stoutenger, A. P. Robinson, J. L. Spees, and D. J. Prockop, "Human 
stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem 
34 
 
 
cells in the hippocampus of mice," Proceedings of the National Academy of Sciences of 
the United States of America, vol. 102, pp. 18171-6, Dec 13 2005. 
[24] F. Hansmann, K. Pringproa, R. Ulrich, Y. Sun, V. Herder, M. Kreutzer, W. Baumgartner, 
and K. Wewetzer, "Highly malignant behavior of a murine oligodendrocyte precursor cell 
line following transplantation into the demyelinated and non-demyelinated central 
nervous system," Cell transplantation, Mar 8 2012. 
[25] O. A. Sulaiman and T. Gordon, "Transforming growth factor-beta and forskolin attenuate 
the adverse effects of long-term Schwann cell denervation on peripheral nerve 
regeneration in vivo," Glia, vol. 37, pp. 206-18, Mar 1 2002. 
[26] N. R. Kobayashi, D. P. Fan, K. M. Giehl, A. M. Bedard, S. J. Wiegand, and W. Tetzlaff, 
"BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, 
stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal 
regeneration," The Journal of neuroscience : the official journal of the Society for 
Neuroscience, vol. 17, pp. 9583-95, Dec 15 1997. 
[27] J. G. Boyd and T. Gordon, "Glial cell line-derived neurotrophic factor and brain-derived 
neurotrophic factor sustain the axonal regeneration of chronically axotomized 
motoneurons in vivo," Experimental neurology, vol. 183, pp. 610-9, Oct 2003. 
[28] M. Grassi and G. Grassi, "Mathematical modelling and controlled drug delivery: matrix 
systems," Current drug delivery, vol. 2, pp. 97-116, Jan 2005. 
[29] J. He, C. Zhong, and J. Mi, "Modeling of drug release from bioerodible polymer 
matrices," Drug delivery, vol. 12, pp. 251-9, Sep-Oct 2005. 
[30] C. K. Sackett and B. Narasimhan, "Mathematical modeling of polymer erosion: 
consequences for drug delivery," International journal of pharmaceutics, vol. 418, pp. 
104-14, Oct 10 2011. 
[31] L. Xia, H. Wan, S. Y. Hao, D. Z. Li, G. Chen, C. C. Gao, J. H. Li, F. Yang, S. G. Wang, 
and S. Liu, "Co-transplantation of neural stem cells and Schwann cells within poly (L-
lactic-co-glycolic acid) scaffolds facilitates axonal regeneration in hemisected rat spinal 
cord," Chinese medical journal, vol. 126, pp. 909-917, Mar 2013. 
35 
 
 
[32] G. Tosi, B. Bortot, B. Ruozi, D. Dolcetta, M. A. Vandelli, F. Forni, and G. M. Severini, 
"Potential use of polymeric nanoparticles for drug delivery across the blood-brain 
barrier," Current medicinal chemistry, Feb 21 2013. 
[33] M. J. Caicco, M. J. Cooke, Y. Wang, A. Tuladhar, C. M. Morshead, and M. S. Shoichet, 
"A hydrogel composite system for sustained epi-cortical delivery of Cyclosporin A to the 
brain for treatment of stroke," Journal of controlled release : official journal of the 
Controlled Release Society, vol. 166, pp. 197-202, Mar 28 2013. 
[34] J. Han, P. Lazarovici, C. Pomerantz, X. Chen, Y. Wei, and P. I. Lelkes, "Co-electrospun 
blends of PLGA, gelatin, and elastin as potential nonthrombogenic scaffolds for vascular 
tissue engineering," Biomacromolecules, vol. 12, pp. 399-408, Feb 14 2011. 
[35] Y. Wang, Y. T. Wei, Z. H. Zu, R. K. Ju, M. Y. Guo, X. M. Wang, Q. Y. Xu, and F. Z. 
Cui, "Combination of hyaluronic acid hydrogel scaffold and PLGA microspheres for 
supporting survival of neural stem cells," Pharmaceutical research, vol. 28, pp. 1406-14, 
Jun 2011. 
[36] S. Y. Tzeng and E. B. Lavik, "Photopolymerizable nanoarray hydrogels deliver CNTF 
and promote differentiation of neural stem cells," Soft Matter, vol. 6, pp. 2208-2215, 
2010. 
[37] J. P. Bertram, M. F. Rauch, K. Chang, and E. B. Lavik, "Using polymer chemistry to 
modulate the delivery of neurotrophic factors from degradable microspheres: delivery of 
BDNF," Pharmaceutical research, vol. 27, pp. 82-91, Jan 2010. 
[38] N. Han, J. Johnson, J. J. Lannutti, and J. O. Winter, "Hydrogel-electrospun fiber 
composite materials for hydrophilic protein release," Journal of controlled release : 
official journal of the Controlled Release Society, vol. 158, pp. 165-70, Feb 28 2012. 
[39] D. Puppi, A. M. Piras, N. Detta, D. Dinucci, and F. Chiellini, "Poly(lactic-co-glycolic 
acid) electrospun fibrous meshes for the controlled release of retinoic acid," Acta 
biomaterialia, vol. 6, pp. 1258-68, Apr 2010. 
[40] C. Y. Wang, J. J. Liu, C. Y. Fan, X. M. Mo, H. J. Ruan, and F. F. Li, "The effect of 
aligned core-shell nanofibres delivering NGF on the promotion of sciatic nerve 
36 
 
 
regeneration," Journal of biomaterials science. Polymer edition, vol. 23, pp. 167-84, 
2012. 
[41] H. Seyednejad, W. Ji, F. Yang, C. F. van Nostrum, T. Vermonden, J. J. van den Beucken, 
W. J. Dhert, W. E. Hennink, and J. A. Jansen, "Coaxially electrospun scaffolds based on 
hydroxyl-functionalized poly(epsilon-caprolactone) and loaded with VEGF for tissue 
engineering applications," Biomacromolecules, vol. 13, pp. 3650-60, Nov 12 2012. 
[42] Y. Wang, M. J. Cooke, C. M. Morshead, and M. S. Shoichet, "Hydrogel delivery of 
erythropoietin to the brain for endogenous stem cell stimulation after stroke injury," 
Biomaterials, vol. 33, pp. 2681-92, Mar 2012. 
[43] R. Gardette, M. Courtois, and J. C. Bisconte, "Prenatal development of mouse central 
nervous structures: time of neuron origin and gradients of neuronal production. A 
radioautographic study," Journal fur Hirnforschung, vol. 23, pp. 415-31, 1982. 
[44] J. Altman and S. A. Bayer, "Development of the diencephalon in the rat. IV. Quantitative 
study of the time of origin of neurons and the internuclear chronological gradients in the 
thalamus," The Journal of comparative neurology, vol. 188, pp. 455-71, Dec 1 1979. 
[45] L. Luo and J. G. Flanagan, "Development of continuous and discrete neural maps," 
Neuron, vol. 56, pp. 284-300, Oct 25 2007. 
[46] L. N. Gillespie, G. M. Clark, P. F. Bartlett, and P. L. Marzella, "BDNF-induced survival 
of auditory neurons in vivo: Cessation of treatment leads to accelerated loss of survival 
effects," Journal of neuroscience research, vol. 71, pp. 785-90, Mar 15 2003. 
[47] T. M. Keenan, J. R. Grinager, A. A. Procak, and C. N. Svendsen, "In vitro localization of 
human neural stem cell neurogenesis by engineered FGF-2 gradients," Integrative biology 
: quantitative biosciences from nano to macro, vol. 4, pp. 1522-31, Nov 19 2012. 
[48] M. C. Dodla and R. V. Bellamkonda, "Differences between the effect of anisotropic and 
isotropic laminin and nerve growth factor presenting scaffolds on nerve regeneration 
across long peripheral nerve gaps," Biomaterials, vol. 29, pp. 33-46, Jan 2008. 
37 
 
 
[49] J. Shi, L. Wang, F. Zhang, H. Li, L. Lei, L. Liu, and Y. Chen, "Incorporating protein 
gradient into electrospun nanofibers as scaffolds for tissue engineering," ACS applied 
materials & interfaces, vol. 2, pp. 1025-30, Apr 2010. 
[50] A. Kunze, A. Valero, D. Zosso, and P. Renaud, "Synergistic NGF/B27 gradients position 
synapses heterogeneously in 3D micropatterned neural cultures," PloS one, vol. 6, p. 
e26187, 2011. 
[51] C. E. Krewson, M. L. Klarman, and W. M. Saltzman, "Distribution of nerve growth factor 
following direct delivery to brain interstitium," Brain research, vol. 680, pp. 196-206, 
1995. 
[52] W. M. Saltzman, M. W. Mak, M. J. Mahoney, E. T. Duenas, and J. L. Cleland, 
"Intracranial delivery of recombinant nerve growth factor: release kinetics and protein 
distribution for three delivery systems," Pharmaceutical research, vol. 16, pp. 232-40, 
Feb 1999. 
[53] M. J. Mahoney, C. Krewson, J. Miller, and W. M. Saltzman, "Impact of cell type and 
density on nerve growth factor distribution and bioactivity in 3-dimensional collagen gel 
cultures," Tissue engineering, vol. 12, pp. 1915-27, Jul 2006. 
[54] R. W. Sirianni, P. Olausson, A. S. Chiu, J. R. Taylor, and W. M. Saltzman, "The 
behavioral and biochemical effects of BDNF containing polymers implanted in the 
hippocampus of rats," Brain research, vol. 1321, pp. 40-50, Mar 19 2010. 
[55] M. S. Shanbhag, J. D. Lathia, M. R. Mughal, N. L. Francis, N. Pashos, M. P. Mattson, and 
M. A. Wheatley, "Neural Progenitor Cells Grown on Hydrogel Surfaces Respond to the 
Product of the Transgene of Encapsulated Genetically Engineered Fibroblasts," 
Biomacromolecules, Oct 13 2010. 
[56] N. D. Dey, M. C. Bombard, B. P. Roland, S. Davidson, M. Lu, J. Rossignol, M. I. 
Sandstrom, R. L. Skeel, L. Lescaudron, and G. L. Dunbar, "Genetically engineered 
mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of 
Huntington's disease," Behavioural brain research, vol. 214, pp. 193-200, Dec 25 2010. 
38 
 
 
[57] X. Zeng, J. Cai, J. Chen, Y. Luo, Z. B. You, E. Fotter, Y. Wang, B. Harvey, T. Miura, C. 
Backman, G. J. Chen, M. S. Rao, and W. J. Freed, "Dopaminergic differentiation of 
human embryonic stem cells," Stem cells, vol. 22, pp. 925-40, 2004. 
[58] M. H. Tuszynski, L. Thal, M. Pay, D. P. Salmon, H. S. U, R. Bakay, P. Patel, A. Blesch, 
H. L. Vahlsing, G. Ho, G. Tong, S. G. Potkin, J. Fallon, L. Hansen, E. J. Mufson, J. H. 
Kordower, C. Gall, and J. Conner, "A phase 1 clinical trial of nerve growth factor gene 
therapy for Alzheimer disease," Nature medicine, vol. 11, pp. 551-5, May 2005. 
[59] K. G. Sharp, A. R. Dickson, S. A. Marchenko, K. M. Yee, P. N. Emery, I. Laidmae, R. 
Uibo, E. S. Sawyer, O. Steward, and L. A. Flanagan, "Salmon fibrin treatment of spinal 
cord injury promotes functional recovery and density of serotonergic innervation," 
Experimental neurology, vol. 235, pp. 345-56, May 2012. 
[60] Y. D. Kwak, C. L. Brannen, T. Qu, H. M. Kim, X. Dong, P. Soba, A. Majumdar, A. 
Kaplan, K. Beyreuther, and K. Sugaya, "Amyloid precursor protein regulates 
differentiation of human neural stem cells," Stem cells and development, vol. 15, pp. 381-
9, Jun 2006. 
[61] J. Park, E. Lim, S. Back, H. Na, Y. Park, and K. Sun, "Nerve regeneration following 
spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based 
biomimetic hydrogel scaffold containing brain-derived neurotrophic factor," Journal of 
biomedical materials research. Part A, vol. 93, pp. 1091-9, Jun 1 2010. 
[62] L. Yu and J. Ding, "Injectable hydrogels as unique biomedical materials," Chemical 
Society reviews, vol. 37, pp. 1473-81, Aug 2008. 
[63] T. A. Rickett, Z. Amoozgar, C. A. Tuchek, J. Park, Y. Yeo, and R. Shi, "Rapidly photo-
cross-linkable chitosan hydrogel for peripheral neurosurgeries," Biomacromolecules, vol. 
12, pp. 57-65, Jan 10 2011. 
[64] N. A. Peppas, Hilt, J.Z., Khademhosseini, A. & Langer, R, "Hydrogels in biology and 
medicine: from molecular principles to bionanotechnology," Advanced Materials, vol. 18, 
pp. 1345-1360, 2006. 
39 
 
 
[65] J. M. Zuidema, M. M. Pap, D. B. Jaroch, F. A. Morrison, and R. J. Gilbert, "Fabrication 
and characterization of tunable polysaccharide hydrogel blends for neural repair," Acta 
biomaterialia, vol. 7, pp. 1634-43, Apr 2011. 
[66] A. Banerjee, M. Arha, S. Choudhary, R. S. Ashton, S. R. Bhatia, D. V. Schaffer, and R. S. 
Kane, "The influence of hydrogel modulus on the proliferation and differentiation of 
encapsulated neural stem cells," Biomaterials, vol. 30, pp. 4695-9, Sep 2009. 
[67] X. Yi, G. Jin, M. Tian, W. Mao, and J. Qin, "Porous chitosan scaffold and ngf promote 
neuronal differentiation of neural stem cells in vitro," Neuro endocrinology letters, vol. 
32, pp. 705-10, 2011. 
[68] L. A. Pfister, M. Papaloizos, H. P. Merkle, and B. Gander, "Hydrogel nerve conduits 
produced from alginate/chitosan complexes," Journal of biomedical materials research. 
Part A, vol. 80, pp. 932-7, Mar 15 2007. 
[69] D. Macaya and M. Spector, "Injectable hydrogel materials for spinal cord regeneration: a 
review," Biomedical materials, vol. 7, p. 012001, Feb 2012. 
[70] B. Song, J. Song, S. Zhang, M. A. Anderson, Y. Ao, C. Y. Yang, T. J. Deming, and M. V. 
Sofroniew, "Sustained local delivery of bioactive nerve growth factor in the central 
nervous system via tunable diblock copolypeptide hydrogel depots," Biomaterials, vol. 
33, pp. 9105-16, Dec 2012. 
[71] Y. Wang, F. Qi, S. Zhu, Z. Ye, T. Ma, X. Hu, J. Huang, and Z. Luo, "A synthetic oxygen 
carrier in fibrin matrices promotes sciatic nerve regeneration in rats," Acta biomaterialia, 
Mar 29 2013. 
[72] G. Perale, F. Rossi, M. Santoro, M. Peviani, S. Papa, D. Llupi, P. Torriani, E. Micotti, S. 
Previdi, L. Cervo, E. Sundstrom, A. R. Boccaccini, M. Masi, G. Forloni, and P. 
Veglianese, "Multiple drug delivery hydrogel system for spinal cord injury repair 
strategies," Journal of controlled release : official journal of the Controlled Release 
Society, vol. 159, pp. 271-80, Apr 30 2012. 
[73] S. Woerly, E. Pinet, L. De Robertis, M. Bousmina, G. Laroche, T. Roitback, L. Vargova, 
and E. Sykova, "Heterogeneous PHPMA hydrogels for tissue repair and axonal 
40 
 
 
regeneration in the injured spinal cord," Journal of biomaterials science. Polymer edition, 
vol. 9, pp. 681-711, 1998. 
[74] J. Doshi and D. H. Reneker, "Electrospinning process and applications of electrospun 
fibers," Journal of Electrostatics, vol. 35, pp. 151-160, 1995. 
[75] S. Ramakrishna, "An Introduction to Electrospinning and Nanofibers," World Scientific 
Publishing Company, 2005. 
[76] S. N. Alhosseini, F. Moztarzadeh, M. Mozafari, S. Asgari, M. Dodel, A. 
Samadikuchaksaraei, S. Kargozar, and N. Jalali, "Synthesis and characterization of 
electrospun polyvinyl alcohol nanofibrous scaffolds modified by blending with chitosan 
for neural tissue engineering," International journal of nanomedicine, vol. 7, pp. 25-34, 
2012. 
[77] X. Zong, H. Bien, C. Y. Chung, L. Yin, D. Fang, B. S. Hsiao, B. Chu, and E. Entcheva, 
"Electrospun fine-textured scaffolds for heart tissue constructs," Biomaterials, vol. 26, pp. 
5330-8, Sep 2005. 
[78] E. D. Boland, G. E. Wnek, D. G. Simpson, K. J. Pawlowski, and G. L. Bowlin, 
"TAILORING TISSUE ENGINEERING SCAFFOLDS USING ELECTROSTATIC 
PROCESSING TECHNIQUES: A STUDY OF POLY(GLYCOLIC ACID) 
ELECTROSPINNING," Journal of Macromolecular Science, Part A, vol. 38, pp. 1231-
1243, 2001/11/30 2001. 
[79] A. Subramanian, U. M. Krishnan, and S. Sethuraman, "Fabrication of uniaxially aligned 
3D electrospun scaffolds for neural regeneration," Biomedical materials, vol. 6, p. 
025004, Apr 2011. 
[80] Z. Ma, Z. Lan, T. Matsuura, and S. Ramakrishna, "Electrospun polyethersulfone affinity 
membrane: membrane preparation and performance evaluation," Journal of 
chromatography. B, Analytical technologies in the biomedical and life sciences, vol. 877, 
pp. 3686-94, Nov 1 2009. 
41 
 
 
[81] L. Yao, N. O'Brien, A. Windebank, and A. Pandit, "Orienting neurite growth in 
electrospun fibrous neural conduits," Journal of biomedical materials research. Part B, 
Applied biomaterials, vol. 90, pp. 483-91, Aug 2009. 
[82] G. T. Christopherson, H. Song, and H. Q. Mao, "The influence of fiber diameter of 
electrospun substrates on neural stem cell differentiation and proliferation," Biomaterials, 
vol. 30, pp. 556-64, Feb 2009. 
[83] J. Wang, R. Ye, Y. Wei, H. Wang, X. Xu, F. Zhang, J. Qu, B. Zuo, and H. Zhang, "The 
effects of electrospun TSF nanofiber diameter and alignment on neuronal differentiation 
of human embryonic stem cells," Journal of biomedical materials research. Part A, vol. 
100, pp. 632-45, Mar 2012. 
[84] J. M. Corey, C. C. Gertz, B. S. Wang, L. K. Birrell, S. L. Johnson, D. C. Martin, and E. L. 
Feldman, "The design of electrospun PLLA nanofiber scaffolds compatible with serum-
free growth of primary motor and sensory neurons," Acta biomaterialia, vol. 4, pp. 863-
75, Jul 2008. 
[85] D. R. Nisbet, A. E. Rodda, M. K. Horne, J. S. Forsythe, and D. I. Finkelstein, "Neurite 
infiltration and cellular response to electrospun polycaprolactone scaffolds implanted into 
the brain," Biomaterials, vol. 30, pp. 4573-80, Sep 2009. 
[86] H. S. Koh, T. Yong, C. K. Chan, and S. Ramakrishna, "Enhancement of neurite outgrowth 
using nano-structured scaffolds coupled with laminin," Biomaterials, vol. 29, pp. 3574-
82, Sep 2008. 
[87] H. W. Kim, H. S. Yu, and H. H. Lee, "Nanofibrous matrices of poly(lactic acid) and 
gelatin polymeric blends for the improvement of cellular responses," Journal of 
biomedical materials research. Part A, vol. 87, pp. 25-32, Oct 2008. 
[88] N. Han, S. S. Rao, J. Johnson, K. S. Parikh, P. A. Bradley, J. J. Lannutti, and J. O. Winter, 
"Hydrogel-electrospun fiber mat composite coatings for neural prostheses," Frontiers in 
neuroengineering, vol. 4, p. 2, 2011. 
42 
 
 
[89] S.-H. Huang, T.-C. Chien, and K.-Y. Hung, "Selective Deposition of Electrospun 
Alginate-Based Nanofibers onto Cell-Repelling Hydrogel Surfaces for Cell-Based 
Microarrays," Current Nanoscience, vol. 7, pp. 267-274, 2011. 
[90] T. Nakaji-Hirabayashi, K. Kato, and H. Iwata, "Improvement of neural stem cell survival 
in collagen hydrogels by incorporating laminin-derived cell adhesive polypeptides," 
Bioconjugate chemistry, vol. 23, pp. 212-21, Feb 15 2012. 
[91] Q. Han, W. Sun, H. Lin, W. Zhao, Y. Gao, Y. Zhao, B. Chen, Z. Xiao, W. Hu, Y. Li, B. 
Yang, and J. Dai, "Linear ordered collagen scaffolds loaded with collagen-binding brain-
derived neurotrophic factor improve the recovery of spinal cord injury in rats," Tissue 
engineering. Part A, vol. 15, pp. 2927-35, Oct 2009. 
[92] E. Y. Egawa, K. Kato, M. Hiraoka, T. Nakaji-Hirabayashi, and H. Iwata, "Enhanced 
proliferation of neural stem cells in a collagen hydrogel incorporating engineered 
epidermal growth factor," Biomaterials, vol. 32, pp. 4737-43, Jul 2011. 
[93] R. E. Gamez Sazo, K. Maenaka, W. Gu, P. M. Wood, and M. B. Bunge, "Fabrication of 
growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their 
biocompatibility with Schwann cells and dorsal root ganglia," Biomaterials, vol. 33, pp. 
8529-39, Nov 2012. 
[94] H. Wang, Q. Zhao, W. Zhao, Q. Liu, X. Gu, and Y. Yang, "Repairing rat sciatic nerve 
injury by a nerve-growth-factor-loaded, chitosan-based nerve conduit," Biotechnology and 
applied biochemistry, vol. 59, pp. 388-94, Sep-Oct 2012. 
[95] H. S. Yoo, T. G. Kim, and T. G. Park, "Surface-functionalized electrospun nanofibers for 
tissue engineering and drug delivery," Advanced drug delivery reviews, vol. 61, pp. 1033-
42, Oct 5 2009. 
[96] Y. I. Cho, J. S. Choi, S. Y. Jeong, and H. S. Yoo, "Nerve growth factor (NGF)-conjugated 
electrospun nanostructures with topographical cues for neuronal differentiation of 
mesenchymal stem cells," Acta biomaterialia, vol. 6, pp. 4725-33, Dec 2010. 
[97] M. K. Horne, D. R. Nisbet, J. S. Forsythe, and C. L. Parish, "Three-dimensional 
nanofibrous scaffolds incorporating immobilized BDNF promote proliferation and 
43 
 
 
differentiation of cortical neural stem cells," Stem cells and development, vol. 19, pp. 843-
52, Jun 2010. 
[98] J. M. Belisle, J. P. Correia, P. W. Wiseman, T. E. Kennedy, and S. Costantino, "Patterning 
protein concentration using laser-assisted adsorption by photobleaching, LAPAP," Lab on 
a chip, vol. 8, pp. 2164-7, Dec 2008. 
[99] H. Lin, B. Chen, B. Wang, Y. Zhao, W. Sun, and J. Dai, "Novel nerve guidance material 
prepared from bovine aponeurosis," Journal of biomedical materials research. Part A, 
vol. 79, pp. 591-8, Dec 1 2006. 
[100] J. Cao, C. Sun, H. Zhao, Z. Xiao, B. Chen, J. Gao, T. Zheng, W. Wu, S. Wu, J. Wang, and 
J. Dai, "The use of laminin modified linear ordered collagen scaffolds loaded with 
laminin-binding ciliary neurotrophic factor for sciatic nerve regeneration in rats," 
Biomaterials, vol. 32, pp. 3939-48, Jun 2011. 
[101] J. Xie, M. R. Macewan, W. Z. Ray, W. Liu, D. Y. Siewe, and Y. Xia, "Radially aligned, 
electrospun nanofibers as dural substitutes for wound closure and tissue regeneration 
applications," ACS nano, vol. 4, pp. 5027-36, Sep 28 2010. 
[102] J. S. Park, H. N. Yang, D. G. Woo, S. Y. Jeon, H. J. Do, S. H. Huh, N. H. Kim, J. H. Kim, 
and K. H. Park, "Exogenous Nurr1 gene expression in electrically-stimulated human 
MSCs and the induction of neurogenesis," Biomaterials, vol. 33, pp. 7300-8, Oct 2012. 
[103] J. Huang, L. Lu, J. Zhang, X. Hu, Y. Zhang, W. Liang, S. Wu, and Z. Luo, "Electrical 
stimulation to conductive scaffold promotes axonal regeneration and remyelination in a 
rat model of large nerve defect," PloS one, vol. 7, p. e39526, 2012. 
[104] M. J. McKasson, L. Huang, and K. R. Robinson, "Chick embryonic Schwann cells 
migrate anodally in small electrical fields," Experimental neurology, vol. 211, pp. 585-7, 
Jun 2008. 
[105] J. Xie, M. R. Macewan, S. M. Willerth, X. Li, D. W. Moran, S. E. Sakiyama-Elbert, and 
Y. Xia, "Conductive Core-Sheath Nanofibers and Their Potential Application in Neural 
Tissue Engineering," Advanced functional materials, vol. 19, pp. 2312-2318, Jul 24 2009. 
44 
 
 
[106] J. Y. Lee, C. A. Bashur, A. S. Goldstein, and C. E. Schmidt, "Polypyrrole-coated 
electrospun PLGA nanofibers for neural tissue applications," Biomaterials, vol. 30, pp. 
4325-35, Sep 2009. 
[107] J. Y. Lee, C. A. Bashur, C. A. Milroy, L. Forciniti, A. S. Goldstein, and C. E. Schmidt, 
"Nerve growth factor-immobilized electrically conducting fibrous scaffolds for potential 
use in neural engineering applications," IEEE transactions on nanobioscience, vol. 11, pp. 
15-21, Mar 2012. 
[108] S. Wang, Y. Zhao, M. Shen, and X. Shi, "Electrospun hybrid nanofibers doped with 
nanoparticles or nanotubes for biomedical applications," Therapeutic delivery, vol. 3, pp. 
1155-69, Oct 2012. 
[109] Y. J. Huang, H. C. Wu, N. H. Tai, and T. W. Wang, "Carbon Nanotube Rope with 
Electrical Stimulation Promotes the Differentiation and Maturity of Neural Stem Cells," 
Small, Jul 2 2012. 
[110] M. Kabiri, M. Soleimani, I. Shabani, K. Futrega, N. Ghaemi, H. H. Ahvaz, E. Elahi, and 
M. R. Doran, "Neural differentiation of mouse embryonic stem cells on conductive 
nanofiber scaffolds," Biotechnology letters, vol. 34, pp. 1357-65, Jul 2012. 
[111] J. Miao, M. Miyauchi, J. S. Dordick, and R. J. Linhardt, "Preparation and characterization 
of electrospun core sheath nanofibers from multi-walled carbon nanotubes and poly(vinyl 
pyrrolidone)," Journal of nanoscience and nanotechnology, vol. 12, pp. 2387-93, Mar 
2012. 
[112] J. Y. Hwang, U. S. Shin, W. C. Jang, J. K. Hyun, I. B. Wall, and H. W. Kim, 
"Biofunctionalized carbon nanotubes in neural regeneration: a mini-review," Nanoscale, 
vol. 5, pp. 487-97, Jan 21 2013. 
[113] Y. J. Huang, H. C. Wu, N. H. Tai, and T. W. Wang, "Carbon nanotube rope with 
electrical stimulation promotes the differentiation and maturity of neural stem cells," 
Small, vol. 8, pp. 2869-77, Sep 24 2012. 
45 
 
 
[114] F. Sabri, J. A. Cole, M. C. Scarbrough, and N. Leventis, "Investigation of polyurea-
crosslinked silica aerogels as a neuronal scaffold: a pilot study," PloS one, vol. 7, p. 
e33242, 2012. 
[115] N. Y. Joo, J. C. Knowles, G. S. Lee, J. W. Kim, H. W. Kim, Y. J. Son, and J. K. Hyun, 
"Effects of phosphate glass fiber-collagen scaffolds on functional recovery of completely 
transected rat spinal cords," Acta biomaterialia, vol. 8, pp. 1802-12, May 2012. 
[116] M. Uemura, M. M. Refaat, M. Shinoyama, H. Hayashi, N. Hashimoto, and J. Takahashi, 
"Matrigel supports survival and neuronal differentiation of grafted embryonic stem cell-
derived neural precursor cells," Journal of Neuroscience Research, vol. 88, pp. 542-51, 
Feb 15 2010. 
[117] M. Widhe, H. Bysell, S. Nystedt, I. Schenning, M. Malmsten, J. Johansson, A. Rising, and 
M. Hedhammar, "Recombinant spider silk as matrices for cell culture," Biomaterials, vol. 
31, pp. 9575-85, Dec 2010. 
[118] M. Lewicka, O. Hermanson, and A. U. Rising, "Recombinant spider silk matrices for 
neural stem cell cultures," Biomaterials, vol. 33, pp. 7712-7, Nov 2012. 
[119] Y. Assal, M. Mie, and E. Kobatake, "The promotion of angiogenesis by growth factors 
integrated with ECM proteins through coiled-coil structures," Biomaterials, vol. 34, pp. 
3315-23, Apr 2013. 
[120] J. Shaikh Mohammed, M. A. Decoster, and M. J. McShane, "Fabrication of interdigitated 
micropatterns of self-assembled polymer nanofilms containing cell-adhesive materials," 
Langmuir : the ACS journal of surfaces and colloids, vol. 22, pp. 2738-46, Mar 14 2006. 
[121] A. Beduer, C. Vieu, F. Arnauduc, J. C. Sol, I. Loubinoux, and L. Vaysse, "Engineering of 
adult human neural stem cells differentiation through surface micropatterning," 
Biomaterials, vol. 33, pp. 504-14, Jan 2012. 
[122] A. Ruiz, L. Buzanska, D. Gilliland, H. Rauscher, L. Sirghi, T. Sobanski, M. Zychowicz, 
L. Ceriotti, F. Bretagnol, S. Coecke, P. Colpo, and F. Rossi, "Micro-stamped surfaces for 
the patterned growth of neural stem cells," Biomaterials, vol. 29, pp. 4766-74, Dec 2008. 
46 
 
 
[123] S. Ilkhanizadeh, A. I. Teixeira, and O. Hermanson, "Inkjet printing of macromolecules on 
hydrogels to steer neural stem cell differentiation," Biomaterials, vol. 28, pp. 3936-43, 
Sep 2007. 
[124] T. Xu, C. A. Gregory, P. Molnar, X. Cui, S. Jalota, S. B. Bhaduri, and T. Boland, 
"Viability and electrophysiology of neural cell structures generated by the inkjet printing 
method," Biomaterials, vol. 27, pp. 3580-8, Jul 2006. 
[125] Y. K. Choi, H. Cho, Y. K. Seo, H. H. Yoon, and J. K. Park, "Stimulation of sub-sonic 
vibration promotes the differentiation of adipose tissue-derived mesenchymal stem cells 
into neural cells," Life sciences, Jul 31 2012. 
[126] Y. J. Chang, C. J. Tsai, F. G. Tseng, T. J. Chen, and T. W. Wang, "Micropatterned 
Stretching System for the Investigation of Mechanical Tension on Neural Stem Cells 
Behavior," Nanomedicine : nanotechnology, biology, and medicine, Aug 23 2012. 
[127] W. S. Leong, S. C. Wu, M. Pal, C. Y. Tay, H. Yu, H. Li, and L. P. Tan, "Cyclic tensile 
loading regulates human mesenchymal stem cell differentiation into neuron-like 
phenotype," Journal of tissue engineering and regenerative medicine, Jul 9 2012. 
[128] C. C. Shen, Y. C. Yang, T. B. Huang, S. C. Chan, and B. S. Liu, "Neural regeneration in a 
novel nerve conduit across a large gap of the transected sciatic nerve in rats with low-
level laser phototherapy," Journal of biomedical materials research. Part A, Feb 20 2013. 
 [129] E. Alleva and N. Francia, "Psychiatric vulnerability: suggestions from animal models and 
role of neurotrophins," Neuroscience and biobehavioral reviews, vol. 33, pp. 525-36, Apr 
2009.  
[130] A. J. Bella, G. Lin, C. S. Lin, D. R. Hickling, C. Morash, and T. F. Lue, "Nerve growth 
factor modulation of the cavernous nerve response to injury," The journal of sexual 
medicine, vol. 6 Suppl 3, pp. 347-52, Mar 2009. 
[131] O. Mwizerwa, P. Das, N. Nagy, S. E. Akbareian, J. D. Mably, and A. M. Goldstein, 
"Gdnf is mitogenic, neurotrophic, and chemoattractive to enteric neural crest cells in the 
embryonic colon," Developmental dynamics : an official publication of the American 
Association of Anatomists, vol. 240, pp. 1402-11, Jun 2011. 
47 
 
 
[132] L. Studer, M. Csete, S. H. Lee, N. Kabbani, J. Walikonis, B. Wold, and R. McKay, 
"Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in 
lowered oxygen," The Journal of neuroscience : the official journal of the Society for 
Neuroscience, vol. 20, pp. 7377-83, Oct 1 2000.  
[133] M. J. Cooke, Y. Wang, C. M. Morshead, and M. S. Shoichet, "Controlled epi-cortical 
delivery of epidermal growth factor for the stimulation of endogenous neural stem cell 
proliferation in stroke-injured brain," Biomaterials, vol. 32, pp. 5688-97, Aug 2011. 
 [134] W. Ye, K. Shimamura, J. L. Rubenstein, M. A. Hynes, and A. Rosenthal, "FGF and Shh 
signals control dopaminergic and serotonergic cell fate in the anterior neural plate," Cell, 
vol. 93, pp. 755-66, May 29 1998. 
 [135] J. Hsieh, J. B. Aimone, B. K. Kaspar, T. Kuwabara, K. Nakashima, and F. H. Gage, "IGF-
I instructs multipotent adult neural progenitor cells to become oligodendrocytes," The 
Journal of cell biology, vol. 164, pp. 111-22, Jan 5 2004. 
 [136] A. M. Vincent, B. C. Mobley, A. Hiller, and E. L. Feldman, "IGF-I prevents glutamate-
induced motor neuron programmed cell death," Neurobiology of disease, vol. 16, pp. 407-
16, Jul 2004. 
 [137] B. Cheng, S. K. Maffi, A. A. Martinez, Y. P. Acosta, L. D. Morales, and J. L. Roberts, 
"Insulin-like growth factor-I mediates neuroprotection in proteasome inhibition-induced 
cytotoxicity in SH-SY5Y cells," Molecular and cellular neurosciences, vol. 47, pp. 181-
90, Jul 2011. 
[138] J. L. Arruda, R. W. Colburn, A. J. Rickman, M. D. Rutkowski, and J. A. DeLeo, "Increase 
of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: 
potential role of IL-6 in neuropathic pain," Brain research. Molecular brain research, vol. 
62, pp. 228-35, Nov 20 1998. 
[139] Q. Ma, L. Sommer, P. Cserjesi, and D. J. Anderson, "Mash1 and neurogenin1 expression 
patterns define complementary domains of neuroepithelium in the developing CNS and 
are correlated with regions expressing notch ligands," The Journal of neuroscience : the 
official journal of the Society for Neuroscience, vol. 17, pp. 3644-52, May 15 1997. 
48 
 
 
[140] Q. Ma, C. Fode, F. Guillemot, and D. J. Anderson, "Neurogenin1 and neurogenin2 control 
two distinct waves of neurogenesis in developing dorsal root ganglia," Genes & 
development, vol. 13, pp. 1717-28, Jul 1 1999. 
 [141] Z. Liu, W. Gao, Y. Wang, W. Zhang, H. Liu, and Z. Li, "Neuregulin-1beta regulates 
outgrowth of neurites and migration of neurofilament 200 neurons from dorsal root 
ganglial explants in vitro," Peptides, vol. 32, pp. 1244-8, Jun 2011. 
[142] G. R. Kaka, T. Tiraihi, A. Delshad, J. Arabkheradmand, and H. Kazemi, "In Vitro 
Differentiation of Bone Marrow Stromal Cells into Oligodendrocyte-like Cells Using 
Triiodothyronine as Inducer," The International journal of neuroscience, vol. 122, pp. 
237-47, May 2012. 
 [143] N. Lowry, S. K. Goderie, P. Lederman, C. Charniga, M. R. Gooch, K. D. Gracey, A. 
Banerjee, S. Punyani, J. Silver, R. S. Kane, J. H. Stern, and S. Temple, "The effect of 
long-term release of Shh from implanted biodegradable microspheres on recovery from 
spinal cord injury in mice," Biomaterials, vol. 33, pp. 2892-901, Apr 2012. 
[144] C. Jia, A. R. Cussen, and C. C. Hegg, "ATP differentially upregulates fibroblast growth 
factor 2 and transforming growth factor alpha in neonatal and adult mice: effect on 
neuroproliferation," Neuroscience, vol. 177, pp. 335-46, Mar 17 2011. 
 [145] S. Park, K. S. Lee, Y. J. Lee, H. A. Shin, H. Y. Cho, K. C. Wang, Y. S. Kim, H. T. Lee, 
K. S. Chung, E. Y. Kim, and J. Lim, "Generation of dopaminergic neurons in vitro from 
human embryonic stem cells treated with neurotrophic factors," Neuroscience letters, vol. 
359, pp. 99-103, Apr 8 2004. 
[146] J. Herz, R. Reitmeir, S. I. Hagen, B. S. Reinboth, Z. Guo, A. Zechariah, A. ElAli, T. R. 
Doeppner, M. Bacigaluppi, S. Pluchino, U. Kilic, E. Kilic, and D. M. Hermann, 
"Intracerebroventricularly delivered VEGF promotes contralesional corticorubral 
plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory 
actions," Neurobiology of disease, vol. 45, pp. 1077-85, Mar 2012. 
 [147] S. S. Ojha, D. R. Stevens, T. J. Hoffman, K. Stano, R. Klossner, M. C. Scott, W. Krause, 
L. I. Clarke, and R. E. Gorga, "Fabrication and characterization of electrospun chitosan 
49 
 
 
nanofibers formed via templating with polyethylene oxide," Biomacromolecules, vol. 9, 
pp. 2523-9, Sep 2008. 
[148] C. Del Gaudio, A. Bianco, M. Folin, S. Baiguera, and M. Grigioni, "Structural 
characterization and cell response evaluation of electrospun PCL membranes: 
micrometric versus submicrometric fibers," Journal of biomedical materials research. 
Part A, vol. 89, pp. 1028-39, Jun 15 2009. 
 [149] S. I. Jeong, I. D. Jun, M. J. Choi, Y. C. Nho, Y. M. Lee, and H. Shin, "Development of 
electroactive and elastic nanofibers that contain polyaniline and poly(L-lactide-co-
epsilon-caprolactone) for the control of cell adhesion," Macromolecular bioscience, vol. 
8, pp. 627-37, Jul 7 2008. 
[150] R. Chen, C. Huang, Q. Ke, C. He, H. Wang, and X. Mo, "Preparation and characterization 
of coaxial electrospun thermoplastic polyurethane/collagen compound nanofibers for 
tissue engineering applications," Colloids and surfaces. B, Biointerfaces, vol. 79, pp. 315-
25, Sep 1 2010. 
 [151] S. I. Jeong, E. K. Ko, J. Yum, C. H. Jung, Y. M. Lee, and H. Shin, "Nanofibrous 
poly(lactic acid)/hydroxyapatite composite scaffolds for guided tissue regeneration," 
Macromolecular bioscience, vol. 8, pp. 328-38, Apr 9 2008. 
[152] M. Li, Y. Guo, Y. Wei, A. G. MacDiarmid, and P. I. Lelkes, "Electrospinning 
polyaniline-contained gelatin nanofibers for tissue engineering applications," 
Biomaterials, vol. 27, pp. 2705-15, May 2006. 
[153] Y. S. Lee, G. Collins, and T. Livingston Arinzeh, "Neurite extension of primary neurons 
on electrospun piezoelectric scaffolds," Acta biomaterialia, vol. 7, pp. 3877-86, Nov 
2011. 
 [154] R. Rotter, C. Kuhn, I. Stratos, M. Beck, T. Mittlmeier, and B. Vollmar, "Erythropoietin 
enhances the regeneration of traumatized tissue after combined muscle-nerve injury," The 
journal of trauma and acute care surgery, vol. 72, pp. 1567-75, Jun 2012. 
50 
 
 
[155] P. Caroni and P. Grandes, "Nerve sprouting in innervated adult skeletal muscle induced 
by exposure to elevated levels of insulin-like growth factors," The Journal of cell biology, 
vol. 110, pp. 1307-17, Apr 1990. 
[156] J. Mey and S. Thanos, "Intravitreal injections of neurotrophic factors support the survival 
of axotomized retinal ganglion cells in adult rats in vivo," Brain research, vol. 602, pp. 
304-17, Feb 5 1993. 
[157] B. H. Li, S. M. Kim, S. B. Yoo, M. J. Kim, J. W. Jahng, and J. H. Lee, "Recombinant 
human nerve growth factor (rhNGF-beta) gene transfer promotes regeneration of crush-
injured mental nerve in rats," Oral surgery, oral medicine, oral pathology and oral 
radiology, vol. 113, pp. e26-34, Mar 2012. 
[158] B. Neuhuber, B. Timothy Himes, J. S. Shumsky, G. Gallo, and I. Fischer, "Axon growth 
and recovery of function supported by human bone marrow stromal cells in the injured 
spinal cord exhibit donor variations," Brain research, vol. 1035, pp. 73-85, Feb 21 2005. 
 [159] J. Luo, H. T. Zhang, X. D. Jiang, S. Xue, and Y. Q. Ke, "Combination of bone marrow 
stromal cell transplantation with mobilization by granulocyte-colony stimulating factor 
promotes functional recovery after spinal cord transection," Acta neurochirurgica, vol. 
151, pp. 1483-92, Nov 2009. 
[160] V. Magnaghi, V. Conte, P. Procacci, G. Pivato, P. Cortese, E. Cavalli, G. Pajardi, E. 
Ranucci, F. Fenili, A. Manfredi, and P. Ferruti, "Biological performance of a novel 
biodegradable polyamidoamine hydrogel as guide for peripheral nerve regeneration," 
Journal of biomedical materials research. Part A, vol. 98, pp. 19-30, Jul 2011. 
[161] T. Liu, J. Xu, B. P. Chan, and S. Y. Chew, "Sustained release of neurotrophin-3 and 
chondroitinase ABC from electrospun collagen nanofiber scaffold for spinal cord injury 
repair," Journal of biomedical materials research. Part A, vol. 100, pp. 236-42, Jan 2012. 
[162] A. Jain, Y. T. Kim, R. J. McKeon, and R. V. Bellamkonda, "In situ gelling hydrogels for 
conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord 
injury," Biomaterials, vol. 27, pp. 497-504, Jan 2006.  
51 
 
 
2.8 Acknowledgments 
Authors wish to thank the National Sciences and Engineering Research Council of Canada 
(NSERC) and New World Laboratories Inc. for their financial support through a Research and 
Development Collaborative grant. 
 
2.9 Conflict of interest statement 
The authors indicate no potential conflict of interest. 
 
 
 
 
 
 
 
 
52 
 
 
CHAPITRE 3 FABRICATION DES FIBRES ET OBTENTION DE 
NEURONES MOTEURS 
3.1 Présentation 
Il apparaît qu’une approche basée sur l’utilisation de fibres électrofilées bénéficie de l’ensemble 
des avantages mis en évidence dans la revue présentée au chapitre précédent. En particulier, 
l’utilisation de fibres ayant une structure cœur-couronne nous a semblé idéale. En effet, en 
utilisant un cœur d’acide poly lactique, un matériau approuvé par la FDA et aux propriétés bien 
connues, il est possible d’obtenir des fibres ayant un diamètre choisi, un tissu de grande porosité 
présentant des propriétés mécaniques répondant aux contraintes d’utilisation chez l’humain. En 
ajoutant à ce cœur une couronne de gélatine, il est possible de rendre le matériau plus favorable à 
l’attachement des cellules à la surface des fibres. Nous avons donc retenu cette technique de 
fabrication pour créer notre structure. Cette technique nous a permis d’obtenir une permettant de 
contrôler la différentiation de cellules en neurones moteurs. Ces résultats ont été soumis dans 
Biomaterials le 20 Août 2013. 
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3.2 Article 2 – Differentiation of neuronal stem cells into motor neurons using 
co-axial electrospun Poly-L-Lactic Acid/gelatin fibers as an instructive 
cue-delivering scaffold 
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Abstract 
Neural stem cells (NSCs) provide promising therapeutic potential for cell replacement 
therapy in spinal cord injury (SCI).  However, high increases of cell viability and poor 
control of cell differentiation remain major obstacles. In this study, we have developed a 
non-woven material made of co-electrospun fibers of poly L-lactic acid and gelatin with a 
degradation rate and mechanical properties similar to peripheral nerve tissue and 
investigated their effect on cell survival and differentiation into motor neuronal lineages 
through the controlled release of retinoic acid (RA) and purmorphamine. Engineered 
Neural Stem-Like Cells (NSLCs) seeded on these fibers, with and without the instructive 
cues, differentiated into β-III-tubulin, HB-9, Islet-1, and choactase positive motor neurons 
by immunostaining, in response to the release of the biomolecules.  In addition, the 
bioactive material not only enhanced the differentiation into motor neuronal lineages but 
also promoted neurite outgrowth. This study elucidated that a combination of electrospun 
fiber scaffolds, neural stem cells, and controlled delivery of instructive cues could lead to 
the development of a better strategy for peripheral nerve injury repair. 
 
Keywords 
Electrospinning, drug delivery, motor neuron, nerve, regeneration, differentiation. 
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3.2.1 Introduction 
Traumatic injury to the spinal cord causes cell death and axonal degeneration resulting in 
functional motor and sensory loss. [163] With 12,000 new cases every year in the US only [164], 
spinal cord injury results in a dramatic loss in life quality. The process of spinal cord repair is 
often complex due to cell death during the first two weeks, the fragile nature of the cells, and the 
appearance of scar tissue that is chemically and mechanically hostile to the re-growth of 
functional tissue. [165] The lack of treatment is directly related to the lack of grafts. In this 
context, cell transplantation therapy using neural stem cells (NSC) provides a promising 
therapeutic potential to replace the damaged cells after SCI. [166] Studies by several groups, 
have demonstrated the potential of restoring functional motor activity after transplanting motor 
neurons derived from neural stem / progenitors cells in paralyzed animals. [163, 167, 168]  
Unfortunately, neural stem cells transplanted into the spinal cord have much tendency to 
differentiate into either astrocytes or oligodendrocytes and rarely undergo differentiation into 
neuronal lineages. [169] [170] Therefore expandable sources of motor cells and optimal scaffolds 
that can promote neural differentiation to specific lineage are needed for effective spinal cord 
repair.  
Various attempts have been made to develop a scaffold to support neural tissue growth, but a 
remaining limitation is related to the need of a continuous delivery of the appropriate 
biomolecule(s). Their periodic injection is not a viable option as it requires several heavy surgical 
procedures, and their concentration should not significantly vary with time.  [171-173] Therefore, 
neural tissue regeneration requires a scaffold permitting the controlled release of specific 
instructive cues in situ, in addition to harboring adequate mechanical properties. In that context, 
electrospun fibers have attracted interest for nerve tissue regeneration. The versatility of 
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electrospinning allows for the fabrication of non-woven meshes of fibers of diameters and 
mechanical properties that can be adjusted by properly choosing the polymer to be processed and 
its concentration. [174] Furthermore, it offers a possibility to incorporate instructive cues within 
the nanofibers, which will serve as controlled delivery system. [175] The high surface-to-volume 
ratio of the electrospun fiber mats as well as their structure that mimics extracellular matrix, 
make them well-adapted scaffolds for neuronal tissue engineering. [176] The high number of 
polymers that can be electrospun also makes it possible to obtain a wide range of material 
properties. [177-178] However, most of these materials need to be coated to improve cell 
adhesion. [174] [180] To reduce this limitation, more and more scientific reports explore the use 
of coaxial electrospun materials where two immiscible polymer solutions are electrospun using 
concentric needles. [181, 182] Two important uses of this technique can be as follows: one is the 
use of extracellular matrix as an outer shell to favor cell contact and the other is the use of the 
inner shell as a reservoir of instructive cues for progressive delivery. [183-185] Another 
characteristic reported in literature is that fiber diameter itself plays an important role in cell 
adhesion and differentiation. [186] In fact, according to this study, an ideal fiber diameter for 
nerve tissue engineering would be between 400 and 600 nm to allow for a maximum neurite 
outgrowth.  
Fibroblast and epidermal growth factors (FGF and EGF) are biomolecules commonly used to 
favor neuronal stem cell (NSC) proliferation, and a cocktail of retinoic acid and purmorphamine 
has been widely shown to promote NSC differentiation into motor neurons. [187] These are 
issued from stem cells by the successive expression of Islet-1 and HB-9 homeogenes. Therefore, 
since choactase is the enzyme that catalyzes the biosynthesis of acetylcholine, the 
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neurotransmitter used by motor neurons, it is commonly admitted that cells positive for Islet-1, 
HB-9 and choactase genes are motor neurons. [188]  
In this work, we have combined the co-electrospinning technology to generate fibers with 
concentric layers of two different polymers, i.e., Poly L-lactic acid (PLLA) as a core and gelatin 
as a shell, with a drug delivery strategy since the gelatin layer was loaded with RA and 
purmorphamine. 
 We thus report the fabrication of co-electrospun fibers with tunable mechanical properties, 
degradation and drug release rates. The nanofibers matrices were characterized morphologically, 
physically, chemically, and biologically to evaluate their efficacy to promote cell survival and 
differentiation towards motor neuronal lineages, which could lead to better strategy for peripheral 
nervous system repair. 
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3.2.2 Materials and methods 
3.2.2.1  Fabrication and characterization of scaffolds of nanofibers 
Fabrication of the fibers 
PLLA (Purac, USA) and gelatin (Sigma, Oakville (ON) Canada) were electrospun using a co-
axial needle (Linari, Pisa, Italy). Briefly, PLLA and gelatin were each dissolved in 
trifluoroethanol (Sigma, Oakville (ON), Canada) to final concentrations of 10% and 7% w/v, 
respectively. Solutions were agitated overnight and the gelatin solution was then heated at 70°C 
to allow gelatin dissolution. Fibers were collected on a rotating drum set to 1400 rpm with an 
electrospinning distance of 15 cm and an applied voltage of 24 kV. The flow rate of both 
solutions was set to 1 mL/h in order to form fibers with an average diameter of 1.6 μm. For the 
fabrication of loaded fibers, retinoic acid (Sigma, Oakville (ON) Canada, R2625) and 
purmorphamine (Cayman Chemical Company, Ann Arbor, MI, USA, 10009634) were dissolved 
in the gelatin solution prior to electrospinning to reach 0.2% w/w purmorphamine and 0.08% 
w/w retinoic acid in the dry gelatin. 
Crosslinking of the fibers 
In order to control the degradation rate of the gelatin outer shell, a crosslinking step was 
performed following fiber fabrication. Co-electrospun fiber mats were cut to fit in a 24 well plate 
containing 0.5% or 0.7% w/w glyceraldehyde in 70% ethanol. Samples were left 19 hours in 
these solutions at room temperature according to the protocol by Sisson et al. [189] 
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Scanning electron microscopy (SEM) 
Samples were imaged after with a JSM-7600TFE microscope equipped with a field emission gun 
from JEOL, after their fabrication and after cell culture. For sample preparation, fibers were dried 
using successive dilutions of ethanol (50%, 75%, 90%, 100%) to avoid shrinkage, and stored 
under vacuum before imaging. All samples were coated with gold (2 times for 15 s). 
Observations were performed with a LEI (low secondary electron image) detector and an 
acceleration voltage of 2kV.  
Transmission electron microscopy (TEM) 
TEM was performed with a JEM-2100F microscope equipped with a field emission gun from 
JEOL, to further confirm the core/shell structure of the fibers. Fibers were co-electrospun directly 
on a copper grid and observed at 200kV for bright field imaging. 
Diameter measurement 
Mat samples were prepared as described for cell culture, and placed in culture medium (50% 
DMEM; 50% F12 during 7days) in an incubator (37°C) to assay for their degradation in culture 
conditions. Fiber diameter was measured with Photoshop software on SEM images at 70 different 
locations for each mat sample for statistical analysis. 
Degradation rate of the gelatin outer shell 
The degradation of the gelatin shell was assayed at different time points by placing fiber mat 
samples in medium in an incubator at 37 °C. Gelatin amount on fiber mats was determined by 
measuring the amount of free amine groups of the gelatin by adapting the Orange II dye protocol 
already published. [190] Fiber mat samples (approx. 3 mg) were incubated 30 min in 1 mL of a 
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solution of 40 mM Orange II dye (pH 3). Unbound Orange II dye was removed by three 1 mL 
washes (pH 3). Remaining dye was then desorbed by immersing the samples in a NaOH solution 
(pH 12, 15 min). Supernatants were acidified with 1% v/v of pure HCl. Eluted Orange II dye 
concentration was then measured by spectrophotometry (480 nm). The amount of eluted Orange 
II dye was normalized relative to the sample weight in order to derive the amount of remaining 
gelatin per g of fiber. 
Mechanical testing 
Mechanical testing was performed using an INSTRON instrument (Norwood, MA, USA). Fiber 
mat samples (2 cm x 5 mm) were crosslinked as for cell culture. Samples were then placed 
between pneumatic grips so that 5 mm of sample remained free. The Young's modulus was 
calculated as the slope of the initial linear part of the curve of the tensile stress (in MPa) plotted 
against tensile extension. 
Enzyme-linked immunosorbent assay (ELISA) 
To determine the release profile of retinoic acid from the fibers, the meshes were cut into round 
patches (16 mm of diameter) and a time dependent release of RA was performed by ELISA. The 
concentration of RA in medium was determined by ELISA assay (MyBiosource, San Diego, 
USA, MBS705877) following the manufacturer’s instructions. Briefly, the samples were placed 
in medium (50% DMEM, 50% F12 with antibiotics) and samples of 25μl of liquid medium were 
taken periodically and placed at -80°C. Taken medium was replaced by fresh, and the suspension 
medium was changed every 3 days. Samples and standards were added to the 96-well plate and 
incubated for 1h at 37°C, which was followed by the addition of TMB substrate (20 min at 
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37°C). Optical density was determined using a plate reader set to 450 nm with a correction at 540 
nm. 
3.2.2.2  NSLC Culture and differentiation 
Cell culture 
Engineered Neural Stem-Like Cells (NSLCs) provided by New World Laboratories Inc. (Laval 
(QC), Canada) were cultured in neural progenitor medium (Lonza, Waskerville, USA, CC-4461) 
supplemented with laminin (Sigma, Oakville (ON), Canada, L2020-1MG) (5mg/L). For 
proliferation studies, cells were cultured on tissue culture plate or fiber mats, with EGF and FGF 
(Lonza, Waskerville, USA) in the medium. For the characterization of NSLC differentiation, 
cells were cultured on fibers loaded with purmorphamine (0.2% w/wgelatin) and retinoic acid 
(0.08% w/wgelatin) without any growth factor in the medium. 
Fiber mat sample preparation and cell seeding 
Fiber mat samples (10% Plla, 7% gelatin) were cut to the size of a well from a 24 well plate (16 
mm) using a punch. Samples were considered sterile after the crosslinking step during which they 
stayed overnight in 70% ethanol. Samples were then rinsed 3 times with PBS (1mL) and cells 
were seeded at 45,000 cells/well in 2 mL of neural progenitor maintenance medium (Lonza, 
Walkerville, MD, USA, CC-4461). Cells were trypsinized and spun down at 1000rpm for 5 min 
and the resultant pellet was re-suspended and dissociated in fresh growth medium. The cell 
suspension (45x10
3
 cells/well) was seeded on nanofibers with and without the presence of 
purmorphamine (0.2% w/wgelatin) and RA (0.08% w/wgelatin). Cells were incubated at 37°C, 5% 
CO2 for 3 weeks and maintenance medium was changed every three days. 
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Immunofluorescent staining and microscopy 
To assess cell phenotype, samples were rinsed three times with 1 mL PBS and fixed in 1 mL 
formaldehyde (3.7%, Sigma) during 30 min. Samples were permeabilized in Triton (0.5%, 20 
min), blocked with donkey serum 5% (Sigma, D9663-10ML, 1 h) and immunostained at 4°C 
overnight with different primary antibodies: goat anti-actin, -nestin, -choactase, -HB-9, -Islet-1 
(sc-1616, sc-21248, sc-19057, sc-22542, sc-23590, all from Santa Cruz Biotech, Dallas, TX, 
USA) or mouse anti-TUJ-1 (Neuromics, Edina, MN, MO15013). Primary antibodies were 
dissolved in 0.1% Triton, 1% donkey serum in PBS, to reach a concentration of 3 μg/mL. After 3 
additional washes, samples were incubated with secondary antibodies: donkey anti-goat or goat 
anti-mouse (sc-362265, sc-362257, Santa Cruz Biotech, Dallas, TX, USA) in 1% donkey serum 
for 1 h. Additional SYTOX green (Invitrogen, Burlington, ON, Canada, S7020) was added 
during 15 min at 1 μM to stain nuclei. Samples were then observed under fluorescent light (488 
nm for TUJ-1 and sytox stainings and 555 nm for other stainings) with a Zeiss microscope. 
Cells were counted on four SYTOX stained 5x images from four different samples with the 
software ImageJ and counts were averaged. Neurite outgrowth was measured on TUJ-1-stained 
40x images. Fluorescence staining was required for these studies due to the opacity of the fibers, 
which prevented normal light observation. 40x images cover a 350μm x 350μm area; 5x images 
cover a 2100μm x 2800μm area. 
Statistical analysis 
Data were analyzed by performing student tests. Results are presented as means ±standard 
deviation. 
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3.2.3 Results 
At first, mats made of co-electrospun fibers consisting of poly L-lactic acid as core and gelatin as 
outer shell loaded with RA and purmorphamine were fabricated and characterized. Then, their 
use to culture NSLC and differentiate them into neurons was investigated. 
3.2.3.1 Mat fabrication and characterization 
Fabrication of mats with controlled fiber diameter 
The co-electrospinning technology was used for the fabrication of fibers with a core/sheath 
structure made of PLLA and gelatin, respectively. Our first attempts were conducted with low 
polymer solution concentrations, i.e., 7% PLLA and 5% gelatin, in an effort to generate sub-
micron diameter fibers since these were reported to harbor a more receptive surface for cell 
contact, attachment and phenotypic differentiation. [174, 186] As expected, fiber diameters of 0.7 
µm were generated, however corresponding mats were extremely fragile and sensitive to static 
electricity. We therefore produced fibers with an average diameter of 1.6 μm, varying from 0.8 to 
2 μm (Fig 4) by increasing PLLA and gelatin concentrations up to 10 and 7%, respectively. 
These fibers were easier to manipulate and mechanical properties of the resulting mats were 
compatible with practical work. Mat thickness of ~ 50 μm was obtained after 20 min of 
electrospinning, this thickness was proportional to fiber winding duration on the rotating 
cylinder. Of interest, while varying polymer concentrations resulted in varying fiber diameters, 
fiber morphology and mat structure were identical for the polymer concentrations that were used 
(Fig 4, compare panels A and B). As expected, the co-electrospun fibers possessed a core/sheath 
structure, as evidenced by TEM imaging. Indeed, as it can be seen in Figure 4 (panel D), fibers 
displayed a well-delimited inner darker area resulting from the different properties of the two 
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polymers constituting the fibers. The loading of the fibers with RA and purmorphamine did not 
affect the morphology of the fibers or that of the mat as deduced from SEM imaging (Fig 1, 
compare panels A and C). 
Fiber crosslinking increased mat stiffness and stability of the gelatin outer layer. 
The fibers were then treated with two concentrations of glyceraldehyde to crosslink the gelatin 
following Sisson’s work on crosslinking methods. [189] The impact of glyceraldehyde 
crosslinking upon mat mechanical properties is reported in Figure 5 A. The Young’s modulus of 
the mat significantly increased upon glyceraldehyde treatment, varying from 0.14 +/- 0.08 MPa 
(untreated fibers) to 1.23 +/- 0.1 MPa for 0.7% w/w glyceraldehyde crosslinking solution. Of 
interest, loading RA in gelatin prior to crosslinking did not affect mat mechanical properties (Fig 
5 A). In parallel, glyceraldehyde-mediated crosslinking induced a loss of elasticity of the mat, as 
evidenced by the decrease in the tensile strain at break of the mats when increasing 
glyceraldehyde concentration (Fig 5 C), while the tensile stress at break increased with the 
crosslinking level (Fig 5 B). 
Note that, overall, the glyceraldehyde-mediated crosslinking did not affect fiber shape according 
to SEM imaging (Fig 6) 
The impact of the crosslinking procedure upon fiber degradation, when fibers were incubated into 
culture medium, was first evaluated by monitoring fiber aspect (Fig 6) and diameter (Fig 7 A) 
changes using SEM images. As can be seen in Figure 6, progressive signs of a new layer 
covering the fibers were observed, a phenomenon that may be attributed to the degradation and 
re-deposition of polymer fragments. Non-crosslinked fibers had a significantly smaller diameter 
at day 0 that their glyceraldehyde-crosslinked counterparts (Fig 7 A), a result that was more 
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likely due to the swelling and drying of the fibers with ethanol (a required step for rinsing and 
sterilizing fibers before cell culture), which might have reduced the amount of gelatin at the fiber 
surface. (Fig 7) This single wash thus appeared to be sufficient to remove a significant, although 
limited, portion of the gelatin on pristine fibers. For pristine fibers, fiber diameter was observed 
to decrease for 5 days to reach an asymptotic limit, more likely due to almost complete 
dissolution of the gelatin layer up to the PLLA core. However, this decrease in fiber diameter was 
significantly reduced by the glyceraldehyde crosslinking treatment of the fiber mats. Indeed, for 
the 0.5% glyceraldehyde treatment, the crosslinked fibers had the same diameter at day 7 as that 
of freshly rinsed non-crosslinked fibers (day 0) (Fig 7 A). In complement to SEM imaging, the 
degradation kinetics of the fiber gelatin outer layer was also evaluated using a dye assay allowing 
for the quantification of free amine groups (Orange II dye). Since, for our fibers, amine groups 
are only present on gelatin, the Orange II dye assay allowed for a quantification of gelatin that 
remained on our fiber mats. For non-crosslinked fibers, results of the Orange II dye assay 
strongly suggested that gelatin was totally dissolved within the first 5 days in culture medium 
(Fig 7 B), in excellent agreement with conclusions drawn from diameter measurements. In 
contrast to pristine fibers, the 0.5% glyceraldehyde treatment drastically reduced the degradation 
rate of gelatin as the latter was still detectable at day 5. Of salient interest, fibers treated with 
0.7% glyceraldehyde harbored more than 80% of their initial gelatin after 25 days of incubation. 
Retinoic acid release was also affected by the gelatin outer layer stability, as revealed by in-
solution RA measurements by ELISA (Fig 8). Indeed, in the case of fibers crosslinked with 0.5% 
glyceraldehyde, an important initial burst in the release of the RA was observed; such a burst was 
not observed in the case of 0.7% glyceraldehyde crosslinked fibers. Apart from this initial burst, 
RA concentrations in the medium were very similar for the two treatments. These concentrations 
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were relatively stable over time with values around 50 +/- 1.8 nM, then reducing to ~25+/-3 nM 
after 6 days in culture medium, to reach ~15+/-1.9 nM on day 10 and 13. The amount of retinoic 
acid present in the medium was quite stable in spite of medium renewal performed at days 3, 6, 9 
and 12. This may be explained by the short half-life (around 17 h) of RA in culture medium. 
[191] Of interest, these RA concentrations in culture medium were within the range of those 
proposed by Hu and Zhang for best neural stem cell differentiation. [188] This fiber mat was thus 
selected to culture and differentiate neuronal stem cells 
 
3.2.3.2 Use of the mat to create an interconnected motor neuron network 
NSLCs proliferated onto the fibers and penetrated within the scaffold 
The mat of electrospun fibers promoted NSLCs proliferation (Fig 9), although at a slower rate 
than those cultured in control wells (Cellbind, data not shown). However, NSLC cultures on fiber 
mats presented fewer aggregates than in control wells, these aggregates being largely interpreted 
in the literature as a symptom of poor surface contact and biocompatibility. Interestingly, NSLC 
cultures on fibers that had not been loaded with any instructive cues reached their maximum cell 
number and plateaued from day 7. Cells then remained quiescent whereas in tissue culture plate 
NSLCs rapidly formed aggregates that detached from the plate around day 14 to form 
neurospheres (Supplementary data, 14). Surprisingly, with instructive cue-loaded fibers, a 
significant (p<0.005) increase of cell number at day 14 was observed, i.e. 4.2 times higher than 
that observed with unloaded fibers (Fig 9). However, cells cultured on these fibers died at day 21. 
Another interesting behavior of the cells cultured on fiber mats being loaded with instructive cues 
was that they also penetrated inside the construct. This phenomenon was revealed by the 
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observation of different focal planes within the same microscopy image (Supplementary data, 
16). Also, SEM images indicated that cells were able to penetrate inside the fiber mesh and that 
their extensions grew along the fibers (Fig 13, G and H). 
NSLCs differentiated into motor neurons when cultured on fibers loaded with 
instructive cues 
Cells cultured on unloaded fibers remained positive for nestin (a marker of pluripotent potential), 
whereas cells cultured on RA- and purmorphamine-loaded fibers were nestin-negative from day 2 
(Fig 10). These cells were characterized by larger diameters and presented more neurite 
extensions (Fig 12). The number and size of neurites increased with culture time; this was in 
stark contrast with cells cultured on unloaded fibers, which presented reduced size and number of 
neurite extensions (Fig 12). During their differentiation into motor neurons, NSLCs successively 
expressed the homeogenes Islet-1 and HB-9 and became positive for choactase, the enzyme 
responsible for the biosynthesis of the neurotransmitter used by motor neurons. Cells cultured on 
unloaded fibers remained negative for these markers during the whole experiment, while 
remaining nestin positive. On the contrary, cells cultured on instructive cue-loaded fibers were 
positive for islet-1 from day 2 (Fig 11 A). The other homeogene tested in our study, HB-9, was 
expressed later, i.e. around day 7, and was present only in nuclei as shown by its systematic co-
localization with SYTOX green staining of the nuclei (Fig 11 E). At last, the cells started to 
produce choactase from day 7, while creating a network of choactase-positive cells around day 14 
(Fig 11 I). Cells being positive to islet-1, HB-9 and choactase were considered to be 
differentiated motor neurons, as largely accepted in the literature. The increase of neurons 
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population on loaded fibers was accompanied by a decrease of nestin, a multipotent markers, 
indicating a loss of multipotency phenotype and the differentiation of the cells. 
Cells grow neurite extensions on loaded fibers 
Cell only presented slight changes in their morphology when cultured on unloaded fibers, while 
those cultured on instructive cue-loaded structures were characterized by a significant increase of 
their neurites length from day 7 (Fig 12 and 13). Cell aggregates were also observed from day 7 
(Fig 12) in cultures with RA- and purmorphamine-loaded fibers, while those aggregates were 
shown to be interconnected in the sample imaged at day 14.  
 
3.2.4 Discussion 
Various strategies have been explored to create adequate scaffold for nerve regeneration. [192-
194] Hydrogels have been well characterized and offer a 3-D structure for cell colonization. Their 
swelling properties and mechanical properties make then good candidates to easily fill an injury 
cavity without further damaging surrounding tissue. [195] These hydrogels have been used to 
deliver instructive cues [196] in situ but the fine control of their drug release rate is a daunting 
task. [197] A limitation to their use is the difficulty to obtain anisotropic structures in order to 
control the topology of the new tissue. [198] Electrospinning is a technique that opens these 
avenues. It is indeed possible to align fibers by increasing the collector rotating speed. Such 
alignment fits the needs for nerve supporting structure development. [199] The co-
electrospinning of gelatin and PLLA has already been shown to be promising for the fabrication 
of fiber mats that closely mimic the architecture of the extracellular matrix. [200] As further 
highlighted in our current study, such an approach provides a material with a biocompatible 
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surface ensuring a good cellular contact via gelatin and decent mechanical properties thanks to 
the PLLA core. Our mats were shown to favor neural stem cell proliferation, colonization, and 
differentiation; furthermore, NSLC were able to penetrate within the mat (Supplementary data, 
16), a very important asset for the generation of a three-dimensional functional biological 
structure.  
Moreover, the mechanical properties of our co-electrospun fiber mats were easily tailored by 
varying gelatin and PLLA concentrations as well as the extent of gelatin crosslinking via 
glyceraldehyde treatment. The Young’s moduli of the mats included in this study were comprised 
between 0.1 and 1.2 MPa, depending on the crosslinking treatment applied to the mat (Figure 5 
A), while values around 0.45 MPa have been reported for peripheral nerves. [201] Therefore the 
mechanical properties of our material closely match those of peripheral nerve tissue and can be 
adjusted around this value for specific use. This is a very important asset that contrasts with 
Young’s moduli of most electrospun mats being significantly higher than that of nerve tissue. 
[202, 203] In addition, the strong elasticity of our material, which can withstand up to 80% 
elongation before rupture, facilitates its manipulation. (Figure 5 C) 
Another advantage of our mats resides in their ability to serve, via their gelatin sheath, as a 
reservoir of instructive cues whose release in situ must be controlled both spatially and 
temporally for tissue engineering purposes. Retinoic acid (RA) and sonic hedgehog are known to 
promote NSLC differentiation into motor neurons. [204] Purmorphamine has also been recently 
demonstrated to activate the sonic hedgehog pathway [205] and thus provoke the differentiation 
of NSLCs into motor neurons when used in combination with RA, hence motivating our choice 
of instructive cues. In that endeavor, fiber loading with selected concentration of retinoic acid did 
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not affect fiber morphology or Young’s modulus (Fig 5), an observation that contrasts with 
previous reports. [206] Tuning the gelatin layer stability via glyceraldehyde crosslinking was a 
key to eliminate significant initial release burst while maintaining a concentration of retinoic acid 
in the medium at about 50 nM. (Fig 8) Such a value corresponded to the concentration suggested 
by Bao-Yang Hu and Su-Chun Zhang to promote NSLC differentiation. [188] After a few days of 
culture, the concentration of retinoic acid decreased around 25 nM, which was still sufficient to 
promote cell differentiation. The release of retinoic acid was then constant for up to 14 days, a 
salient difference with more simple mats that commonly allow constant delivery for less than a 
week. [197, 207] Such a drug release study was not conducted for purmorphamine due to the 
technical difficulties associated with its detection. 
NSLCs cultured on RA- and purmorphamine-loaded fibers differentiated in 14 days. Cell 
progressively differentiated as deduced from the successive expression of 2 homeogenes (Islet-1 
and HB-9) (Fig 11) prior to the detection of choactase-positive cells (Fig 11). Most of the cells 
appeared to be motor neurons, and cells started differentiating before day 2, as they were already 
negative for nestin and positive for Islet-1 at this stage. The expression of the HB-9 gene product 
was observed later, i.e. at day 7. We also observed that choactase was expressed only after 14 
days of culture under these conditions and was present all along the neurites and in the nuclei. At 
this time, cells were positive for Islet-1, HB-9 and choactase, unambiguously confirming their 
motor neuron phenotype. [188]  
Throughout this study, NSLC proliferated well on the fiber mats, although their proliferation was 
faster on tissue culture plate. This observation can be related to the three-dimensional nature of 
the mat allowing for cells migration; this process consumes energy and may thus decrease cell 
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proliferation when compared to growth on the two-dimensional culture plates. Cell number 
significantly increased on RA- and purmorphamine-loaded fibers at day 14. (Fig 9) This is more 
likely due to the mitogen activity of the sonic hedgehog pathway that was activated by 
purmorphamine. [208] Also, cells were shown to aggregate from day 7 (Fig 12) and to die before 
the 21
st
 day of culture on these fibers whereas no sign of aggregation was observed on fibers 
without any instructive cues loaded. These differences suggest that NSLCs, once differentiated 
into motor neurons may require additional biochemical and/or electrical stimulation to remain 
viable. The culture protocol we applied may not provide adequate conditions to prolong cell 
viability. This may not have any negative impact if these cell-bearing structures are implanted 
early. 
At last, of salient interest is the fact that neurite length increased significantly on our instructive 
cue-loaded fiber mats, (8-fold longer at 14 days of culture, Fig 13) whereas a round phenotype 
was observed on pristine fibers. Therefore we observed the creation of extended, mechanically 
connected networks of motor neuron cells in the newly generated tissue in vitro, an extremely 
promising result in the context of the regeneration of an in vivo nerve network. 
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3.2.5 Conclusions 
We here report the fabrication of mats made of co-electrospun fibers of PLLA and gelatin to 
deliver retinoic acid and purmorphamine in situ. This material presented adequate mechanical 
properties and was able to progressively deliver loaded instructive cues. NSLCs cultured on these 
mats successfully proliferated and differentiated rapidly into motor neurons. We thus believe that 
this novel structure can offer mechanical and chemical support for the fabrication of motor nerve 
grafts from NSLCs, either in vitro or in situ. This work may also provide a starting point for 
further fabrication of any kind of neural tissue by loading appropriate instructive cues. 
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3.2.8 Figures 
 
Fig 4. Fiber morphology: SEM images of co-electrospun fibers corresponding to 10% PLLA (core) and 7% gelatin (outer shell) 
(A, C) or 7% PLLA and 5% gelatin (B) without any instructive cues (A, B) or with retinoic acid and purmorphamine in the gelatin 
(C) and TEM image showing the core/shell structure of the fibers (D) 
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Fig 5. Young’s modulus (A), Tensile stress (B) and strain (C) at break of fibers crosslinked with different concentrations of 
glyceraldehyde. 
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Fig 6. SEM images of untreated (A, C, E, G) and crosslinked (B, D, F, H) fibers at different degradation times: day 0 (A, B), day 
3 (C, D), day 5 (E, F) and day 7 (G, H) 
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Fig 7. Evaluation of gelatin layer degradation by (A) fiber diameter measurements from SEM imaging and (B) Orange II dye 
assay after various glyceraldehyde crosslinking treatments. (For panel A, * Indicates student test p<0.05, and ** indicates 
p<0.001) 
 
 
Fig 8. Concentration of retinoic acid released from the fibers in the culture medium. Medium was changed at days 3, 6, 9, and 13. 
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Fig 9. Cell counts on RA- and purmorphamine-loaded fibers or control fibers  
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Fig 10. Nestin and SYTOX staining of cells cultured on control fibers at days 2, 7 and 14  (A, B, C) or RA- and purmorphamine-
loaded fibers at day 2(D). Images are 40x (A, C, D) or 10X (B) 
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Fig 11. Representative images of NSLCs at different time points in culture on RA and purmorphamine loaded fibers (from A to I) 
and fibers without instructive cues (J, K, L, only at day 14). Cell morphology on 40x images obtained with Cells stained for Islet-
1 at day 2 (A), 7 (D), 14 (G), for HB-9 at day 2 (B), 7 (E), 14 (H), and for Choactase at day 2 (C), 7 (F), and 14 (I). 
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Fig 12. Morphological evaluation: cell morphology on 40x images obtained with TUJ-1 staining and SEM images. Cells cultured 
on pure fibers (A, C, E, G) or RA- and purmorphamine-loaded fibers (B, D, F, H) at day 2 (A, B, G), 7 (C, D), and 14 (E,F, H). 
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Fig 13. Neurite length on fibers with or without RA and purmorphamine. (The value at day 14 for pure fibers is under detection 
limit capacity). 
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3.2.9 Supplementary data 
 
Fig 14. Formation of neurospheres on tissue culture plate after seven days of culture. 
 
 
 
Fig 15. Images of cells cultured on fibers and stained with SYTOX green for nuclei at day 2 (A), day 7 (B) and day 14 (C).  
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Fig 16. Cell penetration: at least two different focal planes are present on this 40x image obtained with nucleus staining. 
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CHAPITRE 4 DISCUSSION GÉNÉRALE 
Ce travail a permis de développer une technique de fabrication de fibres permettant la livraison 
de biomolécules in situ afin de favoriser la différenciation de cellules souches neuronales en 
neurones moteurs. Afin de pouvoir juger des différentes techniques et des matériaux à 
disposition, une importante revue de littérature a été réalisée. Elle a permis de définir les 
caractéristiques importantes qu’une structure doit avoir pour aider à la différenciation de cellules 
souches. Les plus importantes sont une topologie et des propriétés mécaniques proches de celles 
de la matrice extracellulaire, une surface favorable au contact et à l’attachement des cellules, et la 
capacité de relâcher progressivement des molécules dans son environnement. Ainsi, nous avons 
pu sélectionner une méthode essentielle : le co-électrofilage. En effet, cette technique nous a 
semblé la plus prometteuse puisqu’elle répond extrêmement bien aux critères de mimétisme de la 
matrice extracellulaire et qu’il nous a semblé possible d’y apporter des modifications pour qu’elle 
satisfasse aux autres critères. Ainsi, nous avons choisi d’ajouter une couche externe de gélatine 
aux fibres afin d’en améliorer les propriétés de contact avec les cellules. L’application d’une 
étape de réticulation de la gélatine permet d’ajuster la vitesse de dégradation et les propriétés 
mécaniques du matériau pour les adapter en fonction de l’utilisation de la structure fabriquée. Ces 
propriétés constituent un avantage important de la méthode proposée puisqu’ils la rendent 
flexible tout en assurant sa totale autonomie : comme souhaité, le matériel fabriqué ne nécessite 
aucune injection ou manipulation pour que les cellules se différencient après leur implantation sur 
la structure. Ce nouveau matériau a permis d’obtenir la différenciation efficace de NSCs en 
neurones moteurs en 14 jours. Ce travail propose une solution pour la fabrication de greffons de 
nerfs moteurs à partir de cellules souches. Ceux-ci pourront alors être implantés chez le patient. 
Une limitation qui est apparue est la mort des cellules pour des temps de culture trop long, 
probablement faute de stimuli complémentaires, bien que cette limitation nous parait liée au 
travail en puits de culture et devrait être supprimée par une implantation sur le patient. 
La grande flexibilité de la méthode fait qu’il serait envisageable de l’utiliser pour générer 
d’autres phénotypes neuronaux, en changeant simplement les molécules délivrés et 
éventuellement en choisissant d’autres propriétés mécaniques. 
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CONCLUSION 
Ce travail propose une méthode efficace de fabrication d’une structure à greffer dans une zone 
blessée de la moelle épinière, ou dans une section blessée d’un nerf, afin de rétablir les fonctions 
du tissu natif. Dans une première partie, ce rapport propose une revue de la littérature, soumise au 
journal Stem cell : reviews and reports, permettant de faire le point sur l’ensemble des méthodes 
envisagées actuellement pour répondre à la problématique de la régénération de tissu nerveux. 
Dans un second temps, ce rapport expose une nouvelle méthode de fabrication d’une structure qui 
permet de faire proliférer et de différencier des cellules souches neuronales en neurones moteurs. 
Cette méthode de fabrication a été soumise au journal Biomaterials. L’utilisation du co-
électrofilage du PLLA et de la gélatine, couplé à différents degrés de réticulation, ont permis 
d’obtenir des fibres aux propriétés mécaniques et à la vitesse de dégradation modulables. Ces 
fibres ont permis de délivrer des signaux moléculaires pour obtenir la différenciation de cellules 
souches neuronales en neurones moteurs. L’intérêt de cette méthode est de permettre la 
fabrication d’une structure qui est implantable et qui, une fois implantée, permet par elle-même 
de promouvoir la prolifération et la différenciation de cellules souches neuronales en nerf moteur, 
sans avoir recours à de multiples chirurgies ou à de lourdes méthodes de livraison de facteurs de 
croissance dans le site blessé. 
À l’avenir, il serait intéressant de tester l’applicabilité de cette méthode pour l’obtention de nerf 
in vivo. D’autre part, cette technique pourrait pouvoir permettre l’obtention de bien d’autres 
phénotypes, en changeant simplement les biomolécules  utilisées en fonction du type de cellule 
que l’on souhaite remplacer chez le patient, capacité qui demande des travaux supplémentaires. 
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ANNEXE 1 – Protocole Orange II 
Préparation des solutions : 
 Solution T3 : pH = 3  
- T3 : 20 µL de HCl pur (12M) dans 50 mL MilliQ 
 Solution T12 : pH = 12  
- NaOH (1M) : 0,8 g dans 20 mL MilliQ 
- T12 : 2,5 mL de NaOH (1M) dans 50 mL 
 Solution orange : 40 mM de orange II dans la solution T3, i.e. 14 mg/mL 
Protocole 
 Adsorption : Les échantillons sont plongés dans la solutions de orange II (1 mL dans 
mon cas) pendant 30 min ) à 40°C. 
 Lavage : Les échantillons sont rincés trios fois avec la solution T3 puis séchés à l’air 
pendant 10 min 
 Désorption : Les échantillons colorés sont immergés dans 1 mL de la solution T12  
pendant 15 min à température ambiante 
 Mesure de l’absorbance à 483 nm 
- Les surnageants sont acidifies par l’ajout de  1% v/v de HCl pur (12M). 
- Calibration 
 Préparer une première solution à 1 mM : 50µL de la solution à 40mM de 
Orange II + 1,95 mL T12 
 1er point : Dilution 1/10 : 1350µL T12 + 150µL 1 mM Orange + 15µL HCl 
pur 
 Points suivants : (5 ou 6) dilutions successives 1/3 : 1000 µL T12 + 10µL 
HCl pur  +  500µL de la solution précédente 
 On obtient ε ≈ 23 UA/mM. 
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ANNEXE 2 – Protocole Immunocoloration 
 
Les échantillons sont rincés trois fois avec du PBS, puis fixés avec une solution de formaldéhyde 
3.7% (1mL par échantillon) pendant 30 minutes. Après trois rinçages au PBS, les cellules sont 
perméabilisées avec 0.5 mL de Triton X100 (0.5%) pendant 20 minutes. Après trois lavages 
additionnels, les échantillons sont placés dans du sérum de singe (5%) pendant 1 heure. 
La solution contenant les anticorps primaires est faite de 1% de sérum de singe, 0.1% Triton dans 
du PBS. 15 μL d’anticorps primaires à 200μg/mL sont dilués dans 1mL de la solution précédente. 
Les échantillons sont placés une nuit à 4 degrés dans 500μL de solution d’anticorps Ires. 
Après 3 nouveaux rinçages au PBS, les échantillons sont placés dans une solution contenant les 
anticorps secondaires (1% de sérum de singe, 15μL d’anticorps à 200μg/mL) pendant une heure. 
Après 3 rinçages additionnels, les échantillons sont placés entre deux lames de verre et imagés 
avec un microscope ZEISS, en lumière fluorescente. 
 
 
